Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Gregory Lip
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Concepts & Ideas
Chemicals & Drugs
Anatomy
Physiology
Procedures
Sign-in to see full Profile
Network (preview)
138
Blann, Andrew
64
Beevers, Gareth
34
MacFadyen, Robert
32
Nadar, Sunil
30
Shantsila, Eduard
27
Watson, Timothy
27
Lim, Hoong Sern
26
Patel, Jeetesh
23
Freestone, Bethan
22
Tayebjee, Muzahir
21
Beevers, Michele
19
Chin, Bernard
18
Lee, Kaeng
17
Chong, Aun Yeong
17
Conway, Dwayne
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Gregory Lip (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Subramaniam Veeran; Davis Russell C; Shantsila Eduard; Lip Gregory Y H
Antithrombotic therapy for heart failure in sinus rhythm.
Fundamental & clinical pharmacology 2009;23(6):705-17.
-
2009: Shantsila Eduard; Lip Gregory Y H
The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms.
Thrombosis and haemostasis 2009;102(5):916-24.
-
2009: Apostolakis Stavros; Shantsila Eduard; Lip Gregory Y H; Lane Deirdre A
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Thrombosis and haemostasis 2009;102(5):914-5.
-
2009: Lane Deirdre A; Lip Gregory Y H; Beevers D Gareth
Improving survival of malignant hypertension patients over 40 years.
American journal of hypertension 2009;22(11):1199-204.
-
2009: Apostolakis Stavros; Shantsila Eduard; Lip Gregory Y H
Vascular imaging as a cardiovascular risk stratification tool in systemic lupus erythematosus.
The Journal of rheumatology 2009;36(10):2141-3.
-
2009: Shantsila Alena; Lip Gregory Y H
Review: combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure.
Evidence-based medicine 2009;14(5):142.
-
2009: Tapp Luke; Wrigley Ben; Lip Gregory Y H
Acute coronary syndromes: oral factor Xa inhibitors in acute coronary syndromes.
Nature reviews. Cardiology 2009;6(10):619-20.
-
2009: Shantsila Eduard; Lip Gregory Y H
Monocytes in acute coronary syndromes.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(10):1433-8.
-
2009: Lip Gregory Y H; Lane Deirdre A
Combination anticoagulant and antiplatelet therapy in atrial fibrillation patients.
Revista española de cardiología 2009;62(9):972-5.
-
2009: Ip John; Waldo Albert L; Lip Gregory Y H; Rothwell Peter M; Martin David T; Bersohn Malcolm M; Choucair Wassim K; Akar Joseph G; Wathen Mark S; Rohani Pooyan; Halperin Jonathan L;
Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
American heart journal 2009;158(3):364-370.e1.
-
2009: Krishnamoorthy Suresh; Lip Gregory Y H; Lane Deirdre A
Alcohol and illicit drug use as precipitants of atrial fibrillation in young adults: a case series and literature review.
The American journal of medicine 2009;122(9):851-856.e3.
-
2009: Shantsila Alena; Lip Gregory Y H
ACP Journal Club. Review: Combining 2 classes of blood pressure-lowering drugs has an approximately additive effect on systolic blood pressure.
Annals of internal medicine 2009;151(4):JC2-11.
-
2009: Shantsila Eduard; Lip Gregory Y H
The endothelium and thrombotic risk in heart failure.
Thrombosis and haemostasis 2009;102(2):185-7.
-
2009: Goon Patrick K Y; Lip Gregory Y H; Stonelake Paul S; Blann Andrew D
Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index.
Neoplasia (New York, N.Y.) 2009;11(8):771-9.
-
2009: Apostolakis Stavros; Shantsila Eduard; Lip Gregory Y H
Angiopoietins and preeclampsia: new perspectives in the quest for markers.
American journal of hypertension 2009;22(8):820.
-
2009: Shantsila Eduard; Lip Gregory Y H
Angiopoietins in arterial hypertension: a mechanism of adaptation or a target for treatment?
Journal of hypertension 2009;27(8):1524-6.
-
2009: Krishnamoorthy Suresh; Lip Gregory Y H
Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil.
Expert opinion on investigational drugs 2009;18(8):1191-6.
-
2009: Lim Hoong Sern; Lip Gregory Y H
Defibrillation testing in patients with atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2009;11(8):1108-9.
-
2009: Shantsila Eduard; Lip Gregory Y H
Endothelial function and endothelial progenitors: possible mediators of the benefits from physical exercise?
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2009;16(4):401-3.
-
2009: Pineda Javier; Marín Francisco; Marco Pascual; Roldán Vanessa; Valencia José; Ruiz-Nodar Juan M; Sogorb Francisco; Lip Gregory Y H
Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers.
International journal of cardiology 2009;136(2):222-5.
-
2009: Shantsila Eduard; Lip Gregory Y H
Monocyte diversity in myocardial infarction.
Journal of the American College of Cardiology 2009;54(2):139-42.
-
2009: Marín Francisco; Kirchhof Paulus; Lip Gregory Y H
Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2009;11(7):842-3.
-
2009: Krishnamoorthy Suresh; Lip Gregory Y H
How safe is the antiarrhythmic drug therapy in atrial fibrillation?
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2009;11(7):837-9.
-
2009: Kirchhof Paulus; Bax Jeroen; Blomstrom-Lundquist Carina; Calkins Hugh; Camm A John; Cappato Ricardo; Cosio Francisco; Crijns Harry; Diener Hans-Christian; Goette Andreas; Israel Carsten W; Kuck Karl-Heinz; Lip Gregory Y H; Nattel Stanley; Page Richard L; Ravens Ursula; Schotten Ulrich; Steinbeck Gerhard; Vardas Panos; Waldo Albert; Wegscheider Karl; Willems Stephan; Breithardt Günter
Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2009;11(7):860-85.
-
2009: Gunarathne Ashan; Patel Jeetesh V; Kausar Shahid; Gammon Brian; Hughes Elizabeth A; Lip Gregory Y H
Glycemic status underlies increased arterial stiffness and impaired endothelial function in migrant South Asian stroke survivors compared to European Caucasians: pathophysiological insights from the West Birmingham Stroke Project.
Stroke; a journal of cerebral circulation 2009;40(7):2298-306.
-
2009: Khoo Chee W; Lip Gregory Y H
Can the NICE guidelines on the management of atrial fibrillation improve its management?
Clinical medicine (London, England) 2009;9(3):207-9.
-
2009: Shantsila Eduard; Lip Gregory Y H; Chong Beng H
Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management.
Chest 2009;135(6):1651-64.
-
2009: Bennett Philip C; Silverman Stanley H; Gill Paramjit S; Lip Gregory Y H
Peripheral arterial disease and Virchow's triad.
Thrombosis and haemostasis 2009;101(6):1032-40.
-
2009: Gunarathne Ashan; Patel Jeetesh V; Gammon Brian; Gill Paramjit S; Hughes Elizabeth A; Lip Gregory Y H
Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical features.
Stroke; a journal of cerebral circulation 2009;40(6):e415-23.
-
2009: Lane Deirdre A; Lip Gregory Y H
Quality of life in older people with atrial fibrillation.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2009;25(1):37-42.
-
2009: Tay Kok Hoon; Khoo Chee Wah; Lip Gregory Y H
Mitral regurgitation reduces systemic coagulation activity in rheumatic heart disease: using fibrin D-dimer as a biomarker of thrombogenesis.
The Journal of heart valve disease 2009;18(3):276-7.
-
2009: Krishnamoorthy Suresh; Lip Gregory Y H
Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
Expert review of cardiovascular therapy 2009;7(5):473-81.
-
2009: Lane Deirdre A; Lip Gregory Y H
Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
Thrombosis and haemostasis 2009;101(5):802-5.
-
2009: Brignole Michele; Vardas Panos; Hoffman Ellen; Huikuri Heikki; Moya Angel; Ricci Renato; Sulke Neil; Wieling Wouter; Auricchio Angelo; Lip Gregory Y H; Almendral Jesus; Kirchhof Paulus; Aliot Etienne; Gasparini Maurizio; Braunschweig Frieder; Lip Gregory Y H; Almendral Jesus; Kirchhof Paulus; Botto Gian Luca;
Indications for the use of diagnostic implantable and external ECG loop recorders.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2009;11(5):671-87.
-
2009: Khoo Chee W; Lip Gregory Y H
Burden of atrial fibrillation.
Current medical research and opinion 2009;25(5):1261-3.
-
2009: Du Xin; Ninomiya Toshiharu; de Galan Bastiaan; Abadir Edward; Chalmers John; Pillai Avinesh; Woodward Mark; Cooper Mark; Harrap Stephen; Hamet Pavel; Poulter Neil; Lip Gregory Y H; Patel Anushka;
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.
European heart journal 2009;30(9):1128-35.
-
2009: Bhatia Gurbir S; Sosin Michael D; Patel Jeetesh V; Grindulis Karl A; Khattak Fazal H; Davis Russell C; Lip Gregory Y H
Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity.
International journal of cardiology 2009;134(1):97-103.
-
2009: Khoo Chee W; Lip Gregory Y H
Clinical outcomes of acute stroke patients with atrial fibrillation.
Expert review of cardiovascular therapy 2009;7(4):371-4.
-
2009: Patel Jeetesh V; Tracey Inessa; Hughes Elizabeth A; Lip Gregory Y H
Unraveling the paradoxical link between obesity and heart failure: the role of adipocytokines.
Expert review of cardiovascular therapy 2009;7(4):337-40.
-
2009: Hamaad Ali; Sosin Michael D; Blann Andrew D; Lip Gregory Y H; MacFadyen Robert J
Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability.
Clinical cardiology 2009;32(4):204-9.
-
2009: Ruiz-Nodar Juan M; Marín Francisco; Sánchez-Payá José; Hurtado José A; Valencia-Martín José; Manzano-Fernández Sergio; Roldán Vanessa; Pérez-Andreu Virginia; Sogorb Francisco; Valdés Mariano; Lip Gregory Y H
Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation.
European heart journal 2009;30(8):932-9.
-
2009: Manzano-Fernández Sergio; Marín Francisco; Pastor-Pérez Francisco J; Caro Cesar; Cambronero Francisco; Lacunza Javier; Pinar Eduardo; Pascual-Figal Domingo A; Valdés Mariano; Lip Gregory Y H
Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting.
Chest 2009;135(4):983-90.
-
2009: Butt Mehmood; Connolly Derek; Lip Gregory Y H
Drug-eluting stents: a comprehensive appraisal.
Future cardiology 2009;5(2):141-57.
-
2009: Tay Kok Hoon; Lip Gregory Y H; Lane Deirdre A
Atrial fibrillation and stroke risk prevention in real-life clinical practice.
Thrombosis and haemostasis 2009;101(3):415-6.
-
2009: Khoo Chee W; Lip Gregory Y H
Acute management of atrial fibrillation.
Chest 2009;135(3):849-59.
-
2009: Lane Deirdre A; Langman Caroline M; Lip Gregory Y H; Nouwen Arie
Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation.
Journal of psychosomatic research 2009;66(3):203-10.
-
2009: Tay Kok Hoon; Lane Deirdre A; Lip Gregory Y H
Challenges facing anticoagulation among the elderly and frail.
Age and ageing 2009;38(2):140-2.
-
2009: Foster Will; Shantsila Eduard; Carruthers David; Lip Gregory Y H; Blann Andrew D
Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction.
Rheumatology (Oxford, England) 2009;48(3):285-8.
-
2009: Shantsila Eduard; Lip Gregory Y H
Variability of response to antiplatelet therapy: what should we do next?
Fundamental & clinical pharmacology 2009;23(1):19-22.
-
2009: Kaireviciute Diana; Aidietis Audrius; Lip Gregory Y H
Atrial fibrillation following cardiac surgery: clinical features and preventative strategies.
European heart journal 2009;30(4):410-25.
-
2009: Jolly Kate; Taylor Rod S; Lip Gregory Y H; Davies Mick; Davis Russell; Mant Jonathan; Singh Sally; Greenfield Sheila; Ingram Jackie; Stubley Jane; Bryan Stirling; Stevens Andrew
A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: the Birmingham Rehabilitation Uptake Maximisation study for patients with Congestive Heart Failure (BRUM-CHF) study.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(2):205-13.
-
2009: Foster Will; Carruthers David; Lip Gregory Y H; Blann Andrew D
Relationships between endothelial, inflammatory and angiogenesis markers in rheumatoid arthritis: implications for cardiovascular pathophysiology.
Thrombosis research 2009;123(4):659-64.
-
2009: Climent Vicente; Marín Francisco; Mainar Luis; Roldán Vanessa; García Amaya; Martínez Juan Gabriel; Lip Gregory Y H
Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation.
International journal of cardiology 2009;132(2):227-32.
-
2009: Cambronero Francisco; Marín Francisco; Roldán Vanessa; Hernández-Romero Diana; Valdés Mariano; Lip Gregory Y H
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.
European heart journal 2009;30(2):139-51.
-
2009: Watson Timothy; Shantsila Eduard; Lip Gregory Y H
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
Lancet 2009;373(9658):155-66.
-
2009: Preissner Klaus T; Lip Gregory Y H
Face to face with basic and clinical research in Thrombosis and Haemostasis.
Thrombosis and haemostasis 2009;101(1):1.
-
2009: Jessani Shahirose; Millane Teri; Lip Gregory Y H
Vascular damage in impaired glucose tolerance: an unappreciated phenomenon?
Current pharmaceutical design 2009;15(29):3417-32.
-
2009: Patel Jeetesh V; Tracey Inessa; Hughes Elizabeth A; Lip Gregory Y H
Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy.
Vascular health and risk management 2009;5():801-10.
-
2009: Apostolakis Stavros; Shantsila Eduard; Lip Gregory Y H
New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?
PharmacoEconomics 2009;27(10):793-5.
-
2009: Ng Kam Chuen Marie J; Lip Gregory Y H; Macfadyen Robert J
Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment.
Cardiovascular therapeutics 2009;27(2):89-95.
-
2009: Goyal Deepak; Logie Ing-Marie; Nadar Sunil K; Lip Gregory Y H; Macfadyen Robert J
Generalized obesity but not that characterized by raised waist-hip ratio is associated with increased perceived breathlessness during treadmill exercise testing.
Cardiovascular therapeutics 2009;27(1):10-6.
-
2009: Patel Jeetesh V; Lim Hoong S; Dubb Kiran; Hughes Elizabeth A; Lip Gregory Y H
Circulating levels of adiponectin, leptin, and tumour necrosis factor alpha in hypertension.
Annals of medicine 2009;41(4):291-300.
-
2009: Chung Irene; Choudhury Anirban; Patel Jeetesh; Lip Gregory Y H
Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Annals of medicine 2009;41(1):45-51.
-
2008: Shantsila Eduard; Lip Gregory Y H
Predicting thrombotic events: creating a complex approach for a complex condition.
Thrombosis and haemostasis 2008;100(6):962-4.
-
2008: Tay Kok Hoon; Lane Deirdre A; Lip Gregory Y H
Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: is clopidogrel any safer than aspirin when combined with warfarin?
Thrombosis and haemostasis 2008;100(6):955-7.
-
2008: Tay Kok-Hoon; Lip Gregory Y H
What "drives" the link between the renin-angiotensin-aldosterone system and the prothrombotic state in hypertension?
American journal of hypertension 2008;21(12):1278-9.
-
2008: Butt Mehmood; Lip Gregory Y H
The endothelium, arterial stiffness, and von Willebrand factor levels in hypertensive women: effects of ethnicity.
American journal of hypertension 2008;21(12):1275-6.
-
2008: Lip Gregory Y H; Butt Mehmood
Gender and the response to blood pressure-lowering treatment.
European heart journal 2008;29(21):2585-6.
-
2008: Idriss Naglaa K; Blann Andrew D; Lip Gregory Y H
Hemoxygenase-1 in cardiovascular disease.
Journal of the American College of Cardiology 2008;52(12):971-8.
-
2008: Manzano-Fernández Sergio; Marin Francisco; Martinez Jose A Hurtado; Cambronero Francisco; Valdés Mariano; Ruiz-Nodar Juan Miguel; Pérez-Berbel Patricio; Lip Gregory Y H
Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting.
QJM : monthly journal of the Association of Physicians 2008;101(9):749-51.
-
2008: Choudhury Anirban; Chung Irene; Panja Nimai; Patel Jeetesh; Lip Gregory Y H
Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
Chest 2008;134(3):574-81.
-
2008: Manzano-Fernández Sergio; Pastor Francisco J; Marín Francisco; Cambronero Francisco; Caro Cesar; Pascual-Figal Domingo A; Garrido Iris P; Pinar Eduardo; Valdés Mariano; Lip Gregory Y H
Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
Chest 2008;134(3):559-67.
-
2008: Sosin Michael D; Patel Jeetesh V; Bhatia Gurbir S; Hughes Elizabeth A; Davis Russell C; Lip Gregory Y H
Effects of white European, African Caribbean and South Asian ethnicity on homocysteine levels in patients with systolic heart failure.
International journal of cardiology 2008;129(1):69-75.
-
2008: Lim Sern H; Lip Gregory Y H; Sanderson John E
Ventricular optimization of biventricular pacing: a systematic review.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(8):901-6.
-
2008: Lip Gregory Y H; Blann Andrew D
Endothelium and fibrinolysis in hypertension: important facets of a prothrombotic state?
Hypertension 2008;52(2):218-9.
-
2008: Gunarathne Ashan; Patel Jeetesh V; Hughes Elizabeth A; Lip Gregory Y H
Measurement of stiffness index by digital volume pulse analysis technique: clinical utility in cardiovascular disease risk stratification.
American journal of hypertension 2008;21(8):866-72.
-
2008: Lim Hoong Sern; Lip Gregory Y H
Asymptomatic atrial fibrillation on device interrogation.
Journal of cardiovascular electrophysiology 2008;19(8):891-3.
-
2008: Lip Gregory Y H
Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
Thrombosis and haemostasis 2008;100(1):11-3.
-
2008: Shantsila Eduard; Lip Gregory Y H
Beyond glucose levels in diabetic patients with coronary artery disease: platelet activity and non-responsiveness to antiplatelet therapy.
Thrombosis and haemostasis 2008;100(1):7-8.
-
2008: Preissner Klaus T; Lip Gregory Y H
Thrombosis and Haemostasis: volume 100 and going strong ...
Thrombosis and haemostasis 2008;100(1):1-2.
-
2008: Lip Gregory Y H
Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.
American heart journal 2008;156(1):1-3.
-
2008: Melenovsky Vojtech; Lip Gregory Y H
Interleukin-8 and atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(7):784-5.
-
2008: Tan Kiat Tsong; Lip Gregory Y H
Imaging of the unstable plaque.
International journal of cardiology 2008;127(2):157-65.
-
2008: Ruiz-Nodar Juan M; Marín Francisco; Lip Gregory Y H
Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation.
JACC. Cardiovascular interventions 2008;1(3):329; author reply 330-1.
-
2008: Singer Daniel E; Albers Gregory W; Dalen James E; Fang Margaret C; Go Alan S; Halperin Jonathan L; Lip Gregory Y H; Manning Warren J;
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest 2008;133(6 Suppl):546S-592S.
-
2008: Patel Jeetesh V; Dwivedi Shridhar; Hughes Elizabeth A; Lip Gregory Y H
Premature coronary artery disease: an inferred cardiovascular variant or a South Asian genetic disorder?
Thrombosis and haemostasis 2008;99(6):991-2.
-
2008: Watson Timothy; Goon Patrick K Y; Lip Gregory Y H
Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension.
Antioxidants & redox signaling 2008;10(6):1079-88.
-
2008: Watson Timothy; Lip Gregory Y H
Identifying AF patients at risk of stroke: can prothrombotic indices improve things?
International journal of cardiology 2008;126(3):299-301.
-
2008: Gasparyan Armen Yuri; Watson Timothy; Lip Gregory Y H
The role of aspirin in cardiovascular prevention: implications of aspirin resistance.
Journal of the American College of Cardiology 2008;51(19):1829-43.
-
2008: Blanc Jean Jacques; Almendral Jesus; Brignole Michele; Fatemi Marjaneh; Gjesdal Knut; González-Torrecilla Esteban; Kulakowski Piotr; Lip Gregory Y H; Shah Dipen; Wolpert Christian;
Consensus document on antithrombotic therapy in the setting of electrophysiological procedures.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(5):513-27.
-
2008: Taggar Jaspal S; Lip Gregory Y H
Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range.
Current medical research and opinion 2008;24(5):1455-8.
-
2008: Lim Hoong Sern; Lip Gregory Y H; Tse Hung-Fat
Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(5):536-9.
-
2008: Freestone Bethan; Gustafsson Finn; Chong Aun Yeong; Corell Pernille; Kistorp Caroline; Hildebrandt Per; Lip Gregory Y H
Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
Chest 2008;133(5):1203-8.
-
2008: Lip Gregory Y H
The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited.
Stroke; a journal of cerebral circulation 2008;39(5):1406-8.
-
2008: Kistorp Caroline; Chong Aun Y; Gustafsson Finn; Galatius Søren; Raymond Ilan; Faber Jens; Lip Gregory Y H; Hildebrandt Per
Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(4):380-7.
-
2008: Nieuwlaat Robby; Dinh Trang; Olsson S Bertil; Camm A John; Capucci Alessandro; Tieleman Robert G; Lip Gregory Y H; Crijns Harry J G M;
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
European heart journal 2008;29(7):915-22.
-
2008: Taggar Jaspal S; Marín Francisco; Lip Gregory Y H
Mortality in patients with atrial fibrillation: improving or not?
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(4):389-90.
-
2008: Boos Christopher J; Balakrishnan Balu; Lip Gregory Y H
The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood.
Journal of thrombosis and thrombolysis 2008;25(2):135-40.
-
2008: Lip Gregory Y H
Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation.
BMJ (Clinical research ed.) 2008;336(7644):614-5.
-
2008: Jolly Kate; Taylor Rod S; Lip Gregory Y H; Singh Sally;
Reproducibility and safety of the incremental shuttle walking test for cardiac rehabilitation.
International journal of cardiology 2008;125(1):144-5.
-
2008: Kakar Puneet; Watson Timothy; Lip Gregory Y H
New approaches to therapy with omega-3 fatty acids.
Current atherosclerosis reports 2008;10(1):79-87.
-
2008: Roldán Vanessa; Marín Francisco; Lip Gregory Y H
Letter by Roldán et al regarding article, "Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass".
Circulation 2008;117(8):e169; author reply e170.
-
2008: Ruiz-Nodar Juan M; Marín Francisco; Hurtado José Antonio; Valencia José; Pinar Eduardo; Pineda Javier; Gimeno Juan Ramón; Sogorb Francisco; Valdés Mariano; Lip Gregory Y H
Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
Journal of the American College of Cardiology 2008;51(8):818-25.
-
2008: Hughes Michael; Lip Gregory Y H;
Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.
Thrombosis and haemostasis 2008;99(2):295-304.
-
2008: Shantsila Eduard; Watson Timothy; Tse Hung-Fat; Lip Gregory Y H
New insights on endothelial progenitor cell subpopulations and their angiogenic properties.
Journal of the American College of Cardiology 2008;51(6):669-71.
-
2008: Boos Christopher J; Lip Gregory Y H
Inflammation and atrial fibrillation: cause or effect?
Heart (British Cardiac Society) 2008;94(2):133-4.
-
2008: Taggar Jaspal S; Watson Timothy; Lip Gregory Y H
Can patients with atrial fibrillation be optimally risk stratified for stroke and thromboembolism?
Stroke; a journal of cerebral circulation 2008;39(2):e24-5; author reply e26.
-
2008: Taggar Jaspal S; Lip Gregory Y H
Risk predictors for lone atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(1):6-8.
-
2008: Taggar Jaspal S; Lip Gregory Y H
The QRISK was less likely to overestimate cardiovascular risk than the Framingham or ASSIGN equations.
ACP journal club 2008;148(1):25.
-
2008: Lane Deirdre A; Lip Gregory Y H
Barriers to anticoagulation in patients with atrial fibrillation: changing physician-related factors.
Stroke; a journal of cerebral circulation 2008;39(1):7-9.
-
2008: Taggar Jaspal S; Lip Gregory Y H
Anticoagulation for elderly patients with atrial fibrillation: not to be neglected.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(1):1-2.
-
2008: Lip Gregory Y H; Watson Timothy
Atrial fibrillation (acute onset).
Clinical evidence 2008;2008():.
-
2008: Patel Jeetesh V; Sosin Michael; Gunarathne Ashan; Hussain Imran; Davis Russell C; Hughes Elizabeth A; Lip Gregory Y H
Elevated angiogenin levels in chronic heart failure.
Annals of medicine 2008;40(6):474-9.
-
2008: Lip Gregory Y H
Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary intervention.
BMJ (Clinical research ed.) 2008;337():a840.
-
2008: Dotsenko Olena; Chackathayil Julia; Patel Jeetesh V; Gill Paramjit S; Lip Gregory Y H
Candidate circulating biomarkers for the cardiovascular disease continuum.
Current pharmaceutical design 2008;14(24):2445-61.
-
2008: Shantsila Eduard; Lip Gregory Y H
'Aspirin resistance' or treatment non-compliance: which is to blame for cardiovascular complications?
Journal of translational medicine 2008;6():47.
-
2008: Rubboli Andrea; Halperin Jonathan L; Airaksinen K E Juhani; Buerke Michael; Eeckhout Eric; Freedman Saul B; Gershlick Anthony H; Schlitt Axel; Tse Hung Fat; Verheugt Freek W A; Lip Gregory Y H
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation.
Annals of medicine 2008;40(6):428-36.
-
2008: Roldán Vanessa; Marín Francisco; González-Conejero Rocío; García-Honrubia Antonio; Martí Silvia; Alfaro Aranzazu; Valdés Mariano; Corral Javier; Lip Gregory Y H; Vicente Vicente
Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk.
Annals of medicine 2008;40(7):553-9.
-
2008: Bennett Philip C; Lane Deirdre A; Lip Gregory Y H
Vital exhaustion and cardiovascular disease: are circulating fibrinogen and D-dimer levels a plausible link?
Stress (Amsterdam, Netherlands) 2008;11(4):247-9.
-
2008: Shantsila Eduard; Watson Timothy; Lip Gregory Y H
Statins and inflammation: reciprocal effectors to endothelial progenitors?
Thrombosis research 2008;123(1):1-4.
-
2008: Patel Jeetesh V; Lim Hoong Sern; Varughese George I; Hughes Elizabeth A; Lip Gregory Y H
Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.
Annals of medicine 2008;40(3):215-22.
-
2008: Gohar Faekah; Greenfield Sheila M; Beevers D Gareth; Lip Gregory Y H; Jolly Kate
Self-care and adherence to medication: a survey in the hypertension outpatient clinic.
BMC complementary and alternative medicine 2008;8():4.
-
2008: Lim Hoong Sern; Tayebjee Muzahir H; Tan Kiat T; Patel Jeetesh V; Macfadyen Robert J; Lip Gregory Y H
Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?
Thrombosis research 2008;122(3):307-13.
-
2008: Freestone Bethan; Chong Aun Yeong; Nuttall Sarah; Lip Gregory Y H
Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Thrombosis research 2008;122(1):85-90.
-
2008: Shantsila Eduard; Watson Timothy; Lip Gregory Y H
Cardioversion and remodelling in atrial fibrillation: Insights beyond the prothrombotic state.
Thrombosis research 2008;121(4):443-5.
-
2008: Boos Christopher J; Balakrishnan Balu; Lip Gregory Y H
The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.
Annals of medicine 2008;40(1):66-73.
-
2008: Chung Irene; Choudhury Anirban; Lip Gregory Y H
Platelet adhesion in congestive heart failure.
Thrombosis research 2008;121(6):885-8.
-
2007: Boos Christopher J; Balakrishnan Balu; Jessani Shahirose; Blann Andrew D; Lip Gregory Y H
Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysfunction.
Chest 2007;132(6):1920-6.
-
2007: Choudhury Anirban; Freestone Bethan; Patel Jeetesh; Lip Gregory Y H
Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation: a link among platelet activation, angiogenesis, and thrombosis?
Chest 2007;132(6):1913-9.
-
2007: Lip Gregory Y H; Rudolf Michael;
Atrial fibrillation: Rate control and digoxin.
BMJ (Clinical research ed.) 2007;335(7631):1169-70.
-
2007: Tello-Montoliu Antonio; Marín Francisco; Patel Jeetesh; Roldán Vanessa; Mainar Luis; Vicente Vicente; Sogorb Francisco; Lip Gregory Y H
Plasma angiogenin levels in acute coronary syndromes: implications for prognosis.
European heart journal 2007;28(24):3006-11.
-
2007: Hamaad Ali; Lip Gregory Y H; Nicholls Deborah; MacFadyen Robert J
Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2007;21(6):437-44.
-
2007: Dotsenko Olena; Chackathayil Julia; Lip Gregory Y H
Cardiac biomarkers: myths, facts and future horizons.
Expert review of molecular diagnostics 2007;7(6):693-7.
-
2007: Boos Christopher J; Lane Deirdre A; Karpha Manas; Beevers D Gareth; Haynes Ronnie; Lip Gregory Y H
Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension.
Chest 2007;132(5):1540-7.
-
2007: Lip Gregory Y H
Post-stenting antithrombotic drug therapy in patients with atrial fibrillation.
The American journal of medicine 2007;120(11):920-2.
-
2007: Lip Gregory Y H; Lim Hoong Sern
Atrial fibrillation and stroke prevention.
Lancet neurology 2007;6(11):981-93.
-
2007: Jaumdally Rumi J; Varma Chetan; Blann Andrew D; MacFadyen Robert J; Lip Gregory Y H
Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplasty.
Chest 2007;132(5):1532-9.
-
2007: Kirchhof Paulus; Auricchio Angelo; Bax Jeroen; Crijns Harry; Camm John; Diener Hans-Christoph; Goette Andreas; Hindricks Gerd; Hohnloser Stefan; Kappenberger Lukas; Kuck Karl-Heinz; Lip Gregory Y H; Olsson Bertil; Meinertz Thomas; Priori Silvia; Ravens Ursula; Steinbeck Gerhard; Svernhage Elisabeth; Tijssen Jan; Vincent Alphons; Breithardt Günter
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2007;9(11):1006-23.
-
2007: Kirchhof Paulus; Auricchio Angelo; Bax Jeroen; Crijns Harry; Camm John; Diener Hans-Christoph; Goette Andreas; Hindricks Gerd; Hohnloser Stefan; Kappenberger Lukas; Kuck Karl-Heinz; Lip Gregory Y H; Olsson Bertil; Meinertz Thomas; Priori Silvia; Ravens Ursula; Steinbeck Gerhard; Svernhage Elisabeth; Tijssen Jan; Vincent Alphons; Breithardt Günter
Outcome parameters for trials in atrial fibrillation: executive summary.
European heart journal 2007;28(22):2803-17.
-
2007: Lip Gregory Y H; Watson Timothy
Stroke prevention in atrial fibrillation--things can only get better.
British journal of clinical pharmacology 2007;64(5):575-7.
-
2007: Thrall Graham; Lane Deirdre; Carroll Douglas; Lip Gregory Y H
A systematic review of the prothrombotic effects of an acute change in posture: a possible mechanism underlying the morning excess in cardiovascular events?
Chest 2007;132(4):1337-47.
-
2007: Freestone Bethan; Chong Aun Yeong; Nuttall Sarah; Blann Andrew D; Lip Gregory Y H
Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation.
Chest 2007;132(4):1253-8.
-
2007: Watson Timothy; Lip Gregory Y H
Combining antiplatelet drugs and oral anticoagulant therapy in atrial fibrillation: acute coronary syndromes and/or percutaneous coronary intervention/stenting revisited.
Stroke; a journal of cerebral circulation 2007;38(10):e107-8.
-
2007: Thrall Graham; Lip Gregory Y H; Carroll Douglas; Lane Deirdre
Depression, anxiety, and quality of life in patients with atrial fibrillation.
Chest 2007;132(4):1259-64.
-
2007: Patel Jeetesh V; Sosin Michael; Lim Hoong Sern; Chung Irene; Panja Nimai; Davis Russell C; Hughes Elizabeth A; Lip Gregory Y H
Raised leptin concentrations among South Asian patients with chronic heart failure.
International journal of cardiology 2007;122(1):34-40.
-
2007: Boos Christopher J; Lip Gregory Y H; Jilma Bernd
Endotoxemia, inflammation, and atrial fibrillation.
The American journal of cardiology 2007;100(6):986-8.
-
2007: Shantsila Eduard; Watson Timothy; Lip Gregory Y H
Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2007;9 Suppl 4():iv37-44.
-
2007: Karthikeyan Vellore J; Lip Gregory Y H
Alpha 1-microglobulin: a further insight into inflammation in hypertension?
American journal of hypertension 2007;20(9):1022-3.
-
2007: Goon Patrick K Y; Lip Gregory Y H
Endothelial progenitor cells, endothelial cell dysfunction and much more: observations from cardiac syndrome X.
Heart (British Cardiac Society) 2007;93(9):1020-1.
-
2007: Jones Miren; Jolly Kate; Raftery James; Lip Gregory Y H; Greenfield Sheila;
'DNA' may not mean 'did not participate': a qualitative study of reasons for non-adherence at home- and centre-based cardiac rehabilitation.
Family practice 2007;24(4):343-57.
-
2007: Goon Patrick K Y; Watson Timothy; Stonelake Paul S; Lip Gregory Y H
The quest for circulating endothelial cell standardization: the peril of platelets.
Cytometry. Part B, Clinical cytometry 2007;72(5):416.
-
2007: Fletcher Kate; Mant Jonathan; Holder Roger; Fitzmaurice David; Lip Gregory Y H; Hobbs F D Richard
An analysis of factors that predict patient consent to take part in a randomized controlled trial.
Family practice 2007;24(4):388-94.
-
2007: Lip Gregory Y H; Tse Hung-Fat
Management of atrial fibrillation.
Lancet 2007;370(9587):604-18.
-
2007: Mant Jonathan; Hobbs F D Richard; Fletcher Kate; Roalfe Andrea; Fitzmaurice David; Lip Gregory Y H; Murray Ellen;
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
Lancet 2007;370(9586):493-503.
-
2007: Fitzmaurice David A; Hobbs F D Richard; Jowett Sue; Mant Jonathon; Murray Ellen T; Holder Roger; Raftery J P; Bryan S; Davies Michael; Lip Gregory Y H; Allan T F
Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial.
BMJ (Clinical research ed.) 2007;335(7616):383.
-
2007: Mant Jonathan; Fitzmaurice David A; Hobbs F D Richard; Jowett Sue; Murray Ellen T; Holder Roger; Davies Michael; Lip Gregory Y H
Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial.
BMJ (Clinical research ed.) 2007;335(7616):380.
-
2007: Watson Timothy; Shantsila Eduard; Lip Gregory Y H
Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation.
International journal of cardiology 2007;120(1):123-4; author reply 125-6.
-
2007: Lip Gregory Y H
Coronary artery disease and ischemic stroke in atrial fibrillation.
Chest 2007;132(1):8-10.
-
2007: Lim Hoong Sern; Lip Gregory Y H
Thromboprophylaxis in acute ischaemic stroke: how can we PREVAIL?
Lancet neurology 2007;6(7):578-9.
-
2007: Jaumdally J Rumi; Varma Chetan; Lip Gregory Y H
Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?
Expert opinion on pharmacotherapy 2007;8(9):1235-43.
-
2007: Goon Patrick K Y; Watson Timothy; Lip Gregory Y H
Circulating endothelial cells in obstructive sleep apnea: an important methodological lesson.
American journal of respiratory and critical care medicine 2007;175(12):1346; author reply 1347.
-
2007: Nieuwlaat Robby; Olsson S Bertil; Lip Gregory Y H; Camm A John; Breithardt Günter; Capucci Alessandro; Meeder Joan G; Prins Martin H; Lévy Samuel; Crijns Harry J G M;
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
American heart journal 2007;153(6):1006-12.
-
2007: Spencer Charles G C; Felmeden Dirk C; Blann Andrew D; Lip Gregory Y H
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
American journal of hypertension 2007;20(6):699-704.
-
2007: Jessani Shahirose; Lip Gregory Y H
Physical fitness and the relationship between hypertension and markers of atherothrombosis.
American journal of hypertension 2007;20(6):676-7.
-
2007: Watson Timothy; Kakar Puneet; Lip Gregory Y H
Cardioversion for atrial fibrillation: does inflammation matter?
The American journal of cardiology 2007;99(11):1617-8.
-
2007: Karthikeyan V J; Lip Gregory Y H
Statins and intra-plaque angiogenesis in carotid artery disease.
Atherosclerosis 2007;192(2):455-6.
-
2007: Caine Graham J; Ryan Peter; Lip Gregory Y H; Blann Andrew D
Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.
Cancer letters 2007;251(2):296-301.
-
2007: Jaumdally Rumi J; Varma Chetan; MacFadyen Robert J; Lip Gregory Y H
Effects of low osmolar contrast (iomeprol) on haemorheology and platelet activation in patients with coronary artery disease.
Journal of thrombosis and thrombolysis 2007;23(3):189-94.
-
2007: Chong Aun Yeong; Freestone Bethan; Lim Hoong Sern; Kistorp Caroline; Gustafsson Finn; Hildebrandt Per; Lip Gregory Y H
Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
International journal of cardiology 2007;119(1):80-2.
-
2007: Choudhury Anirban; Chung Irene; Blann Andrew D; Lip Gregory Y H
Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Journal of the American College of Cardiology 2007;49(19):1957-64.
-
2007: Lane Deirdre A; Lip Gregory Y H
Maintaining therapeutic anticoagulation: the importance of keeping "within range".
Chest 2007;131(5):1277-9.
-
2007: Lip Gregory Y H
Cardioversion of atrial fibrillation: from guidelines to contemporary clinical practice.
International journal of clinical practice 2007;61(5):714-6.
-
2007: Kakar Puneet; Lip Gregory Y H
Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy.
Expert review of cardiovascular therapy 2007;5(3):441-50.
-
2007: Boos Christopher J; Soor Simren K; Kang Delene; Lip Gregory Y H
Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes.
European heart journal 2007;28(9):1092-101.
-
2007: Lip Gregory Y H; Kakar Puneet; Watson Timothy
Atrial fibrillation--the growing epidemic.
Heart (British Cardiac Society) 2007;93(5):542-3.
-
2007: Lip Gregory Y H; Watson Timothy
Stroke prevention in atrial fibrillation: antiplatelet therapy revisited.
European heart journal 2007;28(8):926-8.
-
2007: Jaumdally Rumi; Varma Chetan; Macfadyen Robert J; Lip Gregory Y H
Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?
European heart journal 2007;28(8):929-40.
-
2007: Karthikeyan Vellore J; Beevers D Gareth; Lip Gregory Y H
Ethnic disparities in malignant hypertension: further observations.
Journal of hypertension 2007;25(4):895; author reply 896.
-
2007: Lip Gregory Y H; Patel Jeetesh V; Hughes Elizabeth; Hart Robert G
High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis.
Stroke; a journal of cerebral circulation 2007;38(4):1229-37.
-
2007: Varughese George I; Patel Jeetesh V; Tomson Joseph; Lip Gregory Y H
Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation.
Heart (British Cardiac Society) 2007;93(4):495-9.
-
2007: Caine Graham J; Stonelake Paul S; Lip Gregory Y H; Blann Andrew D
Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
Cancer letters 2007;248(1):131-6.
-
2007: Hurley Victoria; Ireson Rosa; Fletcher Kate; Lip Gregory Y H; Hobbs F D Richard; Mant Jonathan;
A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.
International journal of cardiology 2007;117(2):152-6.
-
2007: Kakar Puneet; Watson Timothy; Lip Gregory Y H
Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor X.
Current opinion in investigational drugs (London, England : 2000) 2007;8(3):256-65.
-
2007: Kakar Puneet; Watson Timothy; Lip Gregory Y H
Rivaroxaban.
Drugs of today (Barcelona, Spain : 1998) 2007;43(3):129-36.
-
2007: Choudhury Anirban; Chung Irene; Blann Andrew D; Lip Gregory Y H
Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.
Chest 2007;131(3):809-15.
-
2007: Jessani Shahirose; Lip Gregory Y H
Is it the post-challenge hyperglycaemic spike or arterial stiffness we should be screening for?
International journal of clinical practice 2007;61(3):356-8.
-
2007: Lip Gregory Y H; Frison Lars; Grind Margaretha;
Effect of hypertension on anticoagulated patients with atrial fibrillation.
European heart journal 2007;28(6):752-9.
-
2007: Shantsila Eduard; Watson Timothy; Lip Gregory Y H
Endothelial progenitor cells in cardiovascular disorders.
Journal of the American College of Cardiology 2007;49(7):741-52.
-
2007: Chong Aun-Yeong; Lip Gregory Y H
Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(2):124-8.
-
2007: Watson Timothy; Shanstila Eduard; Lip Gregory Y H
Modern management of atrial fibrillation.
Clinical medicine (London, England) 2007;7(1):28-34.
-
2007: Lip Gregory Y H; Rudolf Michael; Kakar Puneet
Management of atrial fibrillation: the NICE guidelines.
International journal of clinical practice 2007;61(1):9-11.
-
2007: Watson Timothy; Kakar Puneet; Lip Gregory Y H
Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely.
International journal of clinical practice 2007;61(1):6-9.
-
2007: Patel Jeetesh V; Lee Kaeng W; Tomson Joseph; Dubb Kiran; Hughes Elizabeth A; Lip Gregory Y H
Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction.
International journal of cardiology 2007;115(1):42-5.
-
2007: Goyal Deepak; Tayebjee Muzahir; Lip Gregory Y H; MacFadyen Robert J
South Asian or Afro-Caribbean ethnicity is not associated with altered 1 min heart rate recovery estimates in suspected coronary artery disease patients.
International journal of cardiology 2007;114(2):261-4.
-
2007: Boos Christopher J; Blann Andrew D; Lip Gregory Y H
Assessment of endothelial damage/dysfunction: a focus on circulating endothelial cells.
Methods in molecular medicine 2007;139():211-24.
-
2007: Patel Jeetesh V; Gunarathne Ashan; Lane Deidre; Lim Hoong S; Tracey Inessa; Panja Nimai C; Lip Gregory Y H; Hughes Elizabeth A
Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain - the Healthy Hearts Project.
BMC health services research 2007;7():192.
-
2007: Srivastava Samir; Lip Gregory Y H
Atherosclerotic renal artery stenosis--do we really know what to do?
Blood pressure 2007;16(5):288-90.
-
2007: Jaumdally Rumi J; Varma Chetan; Blann Andrew D; Macfadyen Robert J; Lip Gregory Y H
Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: differences in central versus peripheral levels.
Annals of medicine 2007;39(8):628-33.
-
2007: Lim Hoong Sern; Lip Gregory Y H
From diabetes to metabolic syndrome: a viewpoint on an evolving concept.
Current pharmaceutical design 2007;13(25):2580-3.
-
2007: Karthikeyan V J; Lip Gregory Y H
Hypertension in pregnancy: pathophysiology and management strategies.
Current pharmaceutical design 2007;13(25):2567-79.
-
2007: Kühl Michael; Lip Gregory Y H; Varma Chetan
Management of hypertension in relation to acute coronary syndromes and revascularisation.
Current pharmaceutical design 2007;13(25):2556-66.
-
2007: Goon Patrick K Y; Stonelake Paul S; Lip Gregory Y H
Hypertension, anti-hypertensive therapy and neoplasia.
Current pharmaceutical design 2007;13(25):2539-44.
-
2007: Shantsila Eduard; Watson Timothy; Tse Hung Fat; Lip Gregory Y H
Endothelial colony forming units: are they a reliable marker of endothelial progenitor cell numbers?
Annals of medicine 2007;39(6):474-9.
-
2007: Tello-Montoliu Antonio; Moltó José M; López-Hernández Nicolás; García-Medina Ana; Roldán Vanessa; Sogorb Francisco; Lip Gregory Y H; Marín Francisco
Common carotid artery intima-media thickness and intracranial pulsatility index in non-ST-elevation acute coronary syndromes.
Cerebrovascular diseases (Basel, Switzerland) 2007;24(4):338-42.
-
2007: Jessani Shahirose; Lip Gregory Y H
Measuring soluble CD40 ligand:interleukin-10 ratio as a prognostic marker in acute myocardial infarction: yet another prognostic biomarker?
Thrombosis research 2007;121(3):289-91.
-
2007: Goon Patrick Ky; Watson Timothy; Lip Gregory Y H
New frontiers in cardiovascular disease: circulating endothelial cells and endothelial progenitor cells as cellular biomarkers.
Clinical laboratory 2007;53(5-6):297-9.
-
2007: Kakar Puneet; Boos Christopher J; Lip Gregory Y H
Management of atrial fibrillation.
Vascular health and risk management 2007;3(1):109-16.
-
2007: Jaumdally Rumi J; Varma Chetan; Blann Andrew D; MacFadyen Robert J; Lip Gregory Y H
Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty.
Annals of medicine 2007;39(4):298-305.
-
2007: Boos Christopher J; Beevers Gareth D; Lip Gregory Y H
Assessment of platelet activation indices using the ADVIATM 120 amongst 'high-risk' patients with hypertension.
Annals of medicine 2007;39(1):72-8.
-
2007: Jolly Kate; Tayor Rod S; Lip Gregory Y H; Greenfield Sheila M; Davies Michael K; Davis Russell C; Mant Jonathan W; Singh Sally J; Ingram Jackie T; Stubley Jane; Stevens Andrew J
Home-based exercise rehabilitation in addition to specialist heart failure nurse care: design, rationale and recruitment to the Birmingham Rehabilitation Uptake Maximisation study for patients with congestive heart failure (BRUM-CHF): a randomised controlled trial.
BMC cardiovascular disorders 2007;7():9.
-
2007: Thrall Graham; Lane Deirdre; Carroll Douglas; Lip Gregory Y H
A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: Implications for the pathogenesis of acute coronary syndromes.
Thrombosis research 2007;120(6):819-47.
-
2007: Chung Irene; Choudhury Anirban; Lip Gregory Y H
Platelet activation in acute, decompensated congestive heart failure.
Thrombosis research 2007;120(5):709-13.
-
2007: Choudhury Anirban; Chung Irene; Blann Andrew; Lip Gregory Y H
Platelet adhesion in atrial fibrillation.
Thrombosis research 2007;120(4):623-9.
-
2007: Boos Christopher J; Lip Gregory Y H
Assessment of mean platelet volume in coronary artery disease - what does it mean?
Thrombosis research 2007;120(1):11-3.
-
2007: Shantsila Eduard; Watson Timothy; Lip Gregory Y H
Aspirin resistance: what, why and when?
Thrombosis research 2007;119(5):551-4.
-
2006: Kakar Puneet; Gunarathne Ashan; Lip Gregory Y H
Stroke: ethnic differences do exist.
Expert review of neurotherapeutics 2006;6(12):1769-71.
-
2006: Watson Timothy; Lip Gregory Y H
Management of atrial fibrillation.
Herz 2006;31(9):849-56.
-
2006: Lip Gregory Y H; Karpha Manas
Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.
Chest 2006;130(6):1823-7.
-
2006: Nieuwlaat Robby; Capucci Alessandro; Lip Gregory Y H; Olsson S Bertil; Prins Martin H; Nieman Fred H; López-Sendón José; Vardas Panos E; Aliot Etienne; Santini Massimo; Crijns Harry J G M;
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
European heart journal 2006;27(24):3018-26.
-
2006: Kakar Puneet; Lane Deirdre; Lip Gregory Y H
Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation: a useful complement to stroke risk stratification schema.
Chest 2006;130(5):1296-9.
-
2006: Chung Irene; Lip Gregory Y H
Platelets and heart failure.
European heart journal 2006;27(22):2623-31.
-
2006: Hamaad Ali; Kaeng Lee W; Lip Gregory Y H; MacFadyen Robert J
Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2006;20(5):359-64.
-
2006: Kakar Puneet; Lip Gregory Y H
Atrial fibrillation and stroke prevention.
Expert review of neurotherapeutics 2006;6(10):1523-30.
-
2006: Boos Christopher J; Lip Gregory Y H; Blann Andrew D
Circulating endothelial cells in cardiovascular disease.
Journal of the American College of Cardiology 2006;48(8):1538-47.
-
2006: Jessani Shahirose; Lip Gregory Y H
Death or heart failure post acute myocardial infarction? The role of cardiac biomarkers.
Journal of cardiac failure 2006;12(8):641-3.
-
2006: Goon Patrick K Y; Lip Gregory Y H
Proteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes.
Journal of thrombosis and thrombolysis 2006;22(2):155-6.
-
2006: Boos Christopher J; Lane Deirdre A; Kang Delene; Goon Patrick K Y; Blann Andrew D; Lip Gregory Y H
Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood.
Journal of thrombosis and thrombolysis 2006;22(2):125-31.
-
2006: Boos Christopher J; Lip Gregory Y H
C-reactive protein and lone atrial fibrillation: potential confounders.
The American journal of cardiology 2006;98(7):991-2.
-
2006: Nadar Sunil; Blann Andrew D; Lip Gregory Y H
Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
American journal of hypertension 2006;19(9):970-7; discussion 978.
-
2006: Karthikeyan Vellore J; Lip Gregory Y H
Vasculoprotective effects of angiotensin receptor blockers: beyond the renin-angiotensin-aldosterone system?
Journal of hypertension 2006;24(9):1715-7.
-
2006: Lip Gregory Y H; Lane Deirdre; Van Walraven Carl; Hart Robert G
Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation.
Stroke; a journal of cerebral circulation 2006;37(9):2294-300.
-
2006: Goon Patrick K Y; Lip Gregory Y H
Arterial disease and venous thromboembolism: a modern paradigm?
Thrombosis and haemostasis 2006;96(2):111-2.
-
2006: Shantsila Eduard; Watson Timothy; Lip Gregory Y H
Atrial fibrillation post-cardiac surgery: changing perspectives.
Current medical research and opinion 2006;22(8):1437-41.
-
2006: Lip Gregory Y H; Tello-Montoliu Antonio
Management of atrial fibrillation.
Heart (British Cardiac Society) 2006;92(8):1177-82.
-
2006: Lip Gregory Y H; Watson Timothy; Shantsila Eduard
Anticoagulation for stroke prevention in atrial fibrillation: is gender important?
European heart journal 2006;27(16):1893-4.
-
2006: Lee Kaeng W; Blann Andrew D; Lip Gregory Y H
Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
International journal of cardiology 2006;111(2):302-8.
-
2006: Jolly Kate; Taylor Rod S; Lip Gregory Y H; Stevens Andrew
Home-based cardiac rehabilitation compared with centre-based rehabilitation and usual care: a systematic review and meta-analysis.
International journal of cardiology 2006;111(3):343-51.
-
2006: Lip Gregory Y H
Antithrombotic therapy: standard therapy in essential hypertension?
Progress in cardiovascular diseases 2006;49(1):11-5.
-
2006: Goon Patrick K Y; Boos Christopher J; Stonelake Paul S; Blann Andrew D; Lip Gregory Y H
Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison.
Thrombosis and haemostasis 2006;96(1):45-52.
-
2006: Lip Gregory Y H
Aspirin for prevention of stroke in atrial fibrillation.
Stroke; a journal of cerebral circulation 2006;37(7):1640.
-
2006: Watson Timothy; Shantsila Eduard; Lip Gregory Y H
Pharmacotherapy for atrial fibrillation: is rhythm control achievable?
Expert opinion on pharmacotherapy 2006;7(9):1105-7.
-
2006: Roldán Vanessa; Marín Francisco; García Amaya; Tello-Montoliu Antonio; Lip Gregory Y H
Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?
International journal of cardiology 2006;110(2):265-6.
-
2006: Lane Deirdre A; Ponsford Jennie; Shelley Alison; Sirpal Anu; Lip Gregory Y H
Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme. The West Birmingham Atrial Fibrillation Project.
International journal of cardiology 2006;110(3):354-8.
-
2006: Lane Deirdre A; Boos Christopher J; Lip Gregory Y H
Anticoagulation control with vitamin K antagonists: how well are we doing?
Chest 2006;129(5):1122-4.
-
2006: Thrall Graham; Lane Deirdre; Carroll Douglas; Lip Gregory Y H
Quality of life in patients with atrial fibrillation: a systematic review.
The American journal of medicine 2006;119(5):448.e1-19.
-
2006: Boos Christopher J; Lip Gregory Y H
Urotensin and cardiovascular risk among patients with end-stage renal disease: fact or fiction?
American journal of hypertension 2006;19(5):511-2.
-
2006: Tan Kiat T; Lip Gregory Y H
Platelet microparticles and platelet adhesion: therapeutic implications for the prevention and treatment of stroke.
Current treatment options in cardiovascular medicine 2006;8(3):251-8.
-
2006: Tello-Montoliu Antonio; Roldán Vanessa; Climent Vicente E; Sogorb Francisco; Lip Gregory Y H; Marín Francisco
Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?
Journal of thrombosis and thrombolysis 2006;21(2):163-6.
-
2006: Climent Vicente E; Picó Antonio; Sogorb Francisco; Aznar Silvia; Lip Gregory Y H; Marín Francisco
Growth hormone therapy and the heart.
The American journal of cardiology 2006;97(7):1097-102.
-
2006: Heeringa Jan; van der Kuip Deirdre A M; Hofman Albert; Kors Jan A; van Herpen Gerard; Stricker Bruno H Ch; Stijnen Theo; Lip Gregory Y H; Witteman Jacqueline C M
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.
European heart journal 2006;27(8):949-53.
-
2006: Bhatia Gurbir S; Sosin Michael D; Patel Jeetesh V; Grindulis Karl A; Khattak Fazal H; Hughes Elizabeth A; Lip Gregory Y H; Davis Russell C
Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden?
Journal of the American College of Cardiology 2006;47(6):1169-74.
-
2006: Lip Gregory Y H
Viewpoint.
Circulation 2006;113(9):f33-4.
-
2006: Watson Timothy; Lip Gregory Y H
Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better?
International journal of clinical practice 2006;60(3):252-5.
-
2006: Chong Aun Yeong; Freestone Bethan; Patel Jeetesh; Lim Hoong Sern; Hughes Elizabeth; Blann Andrew D; Lip Gregory Y H
Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
The American journal of cardiology 2006;97(5):671-5.
-
2006: Chong Aun Yeong; Lip Gregory Y H; Freestone Bethan; Blann Andrew D
Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(2):167-72.
-
2006: Karthikeyan V J; Lip Gregory Y H
Review: Angiotensin converting enzyme inhibitors and angiotensin receptor blockers prevent atrial fibrillation.
Evidence-based medicine 2006;11(1):15.
-
2006: Boos Christopher J; Lip Gregory Y H
Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.
Journal of the American College of Cardiology 2006;47(4):889-90; author reply 890-1.
-
2006: Karthikeyan V J; Lip Gregory Y H
Blood pressure control and prevention of stroke.
Expert review of neurotherapeutics 2006;6(2):203-12.
-
2006: Karthikeyan V J; Lip Gregory Y H
Pulse pressure and carotid atherosclerosis: an important link revisited?
International journal of clinical practice 2006;60(2):127-30.
-
2006: Karthikeyan V J; Lip Gregory Y H
Matrix metalloproteinases and hypertension: a link between left ventricular hypertrophy and diastolic dysfunction?
The Tohoku journal of experimental medicine 2006;208(2):93-7.
-
2006: Boos Christopher J; Lip Gregory Y H
Assessment of hemostatic risk factors in predicting arterial thrombotic events.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(2):e18.
-
2006: Hamaad Ali; Ghattas Angie; Hirani Fatima; Lip Gregory Y H; MacFadyen Robert J
Sudden death is less common than might be expected in underprivileged ethnic minorities at high cardiovascular risk.
International journal of cardiology 2006;107(2):235-40.
-
2006: Marinskis Germanas; Lip Gregory Y H; Aidietis Audrius; Jurkuvenas Paulius; Kaireviciute Diana; Jezov Vladimir; Bagdonas Kestutis; Serpytis Pranas; Laucevicius Aleksandras
Blood oxygen saturation during atrio-ventricular dissociation with wide-QRS complex tachycardias.
International journal of cardiology 2006;107(1):134-5.
-
2006: Bacon Simon L; Ring Christopher; Hee Foo Li Saw; Lip Gregory Y H; Blann Andrew D; Lavoie Kim L; Carroll Douglas
Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients.
Biological psychology 2006;71(2):162-70.
-
2006: Tayebjee Muzahir H; Lip Gregory Y H; Tan Kiat T; MacFadyen Robert J
Abnormal circulating neutrophil linked matrix metalloproteinase -9 in stable coronary artery disease.
Thrombosis and haemostasis 2006;95(1):202-4.
-
2006: Choudhury Anirban; Goyal Deepak; Lip Gregory Y H
Ximelagatran.
Drugs of today (Barcelona, Spain : 1998) 2006;42(1):3-19.
-
2006: Blann Andrew D; Lip Gregory Y H
Venous thromboembolism.
BMJ (Clinical research ed.) 2006;332(7535):215-9.
-
2006: Boos Christopher J; Goon Patrick K Y; Lip Gregory Y H
The endothelium, inflammation, and coagulation in sepsis.
Clinical pharmacology and therapeutics 2006;79(1):20-2.
-
2006: Marín Francisco; Pascual Domingo A; Roldán Vanessa; Arribas José María; Ahumada Miguel; Tornel Pedro Luis; Oliver Clara; Gómez-Plana Jesús; Lip Gregory Y H; Valdés Mariano
Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.
The American journal of cardiology 2006;97(1):55-60.
-
2006: Boos Christopher J; Anderson Richard A; Lip Gregory Y H
Is atrial fibrillation an inflammatory disorder?
European heart journal 2006;27(2):136-49.
-
2006: Shantsila Eduard; Watson Timothy; Lip Gregory Y H
Anticoagulation for stroke prevention: high effectiveness, more cost benefit?
PharmacoEconomics 2006;24(10):1035-8.
-
2006: Patel Jeetesh V; Cummings David E; Girod John P; Mascarenhas Alwin V; Hughes Elizabeth A; Gupta Manjula; Lip Gregory Y H; Reddy Sethu; Brotman Daniel J
Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment.
Journal of negative results in biomedicine 2006;5():14.
-
2006: Boos Christopher J; Lip Gregory Y H
Is hypertension an inflammatory process?
Current pharmaceutical design 2006;12(13):1623-35.
-
2006: Jaumdally J Rumi; Lip Gregory Y H; Varma Chetan
Traditional risk factors for coronary atherosclerosis in Indo Asians: the need for a reappraisal.
Current pharmaceutical design 2006;12(13):1611-21.
-
2006: Varughese George I; Patel Jeetesh V; Lip Gregory Y H; Varma Chetan
Novel concepts of statin therapy for cardiovascular risk reduction in hypertension.
Current pharmaceutical design 2006;12(13):1593-609.
-
2006: Nadar Sunil K; Tayebjee Muzahir H; Messerli Franz; Lip Gregory Y H
Target organ damage in hypertension: pathophysiology and implications for drug therapy.
Current pharmaceutical design 2006;12(13):1581-92.
-
2006: Lim Hoong Sern; MacFadyen Robert J; Bakris George; Lip Gregory Y H
The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management.
Current pharmaceutical design 2006;12(13):1567-79.
-
2006: Boos Christopher J; Lip Gregory Y H
Ximelagatran: an eulogy.
Thrombosis research 2006;118(3):301-4.
-
2006: Freestone Bethan; Chong Aun Yeong; Blann Andrew D; Lip Gregory Y H
The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.
Thrombosis research 2006;118(4):479-85.
-
2006: Lip Gregory Y H; Varma Chetan
Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not?
Thrombosis research 2006;118(4):429-32.
-
2006: Lip Gregory Y H; Edwards Steven J
Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.
Thrombosis research 2006;118(3):321-33.
-
2006: Lee Kaeng W; Blann Andrew D; Lip Gregory Y H
Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction.
Thrombosis research 2006;118(3):305-12.
-
2006: Varma Chetan; Lip Gregory Y H
Failed reperfusion with thrombolysis--the effect of a local environment?
Thrombosis research 2006;118(2):185-7.
-
2006: Thrall Graham; Lane Deirdre; Lip Gregory Y H
Differences in the platelet reactivity response to mental stress in cardiac syndrome X patients compared to known coronary artery disease patients: concepts, explanations and methodological weaknesses.
Thrombosis research 2006;117(3):351-2.
-
2006: Brotman Daniel J; Girod John P; Posch Amy; Jani Jayesh T; Patel Jeetesh V; Gupta Manjula; Lip Gregory Y H; Reddy Sethu; Kickler Thomas S
Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers.
Thrombosis research 2006;118(2):247-52.
-
2006: Lip Gregory Y H; Freestone Bethan
Cardioversion and the endothelium in atrial fibrillation.
Thrombosis research 2006;117(3):231-3.
-
2005: Lip Gregory Y H
Atrial fibrillation (recent onset).
Clinical evidence 2005;(14):71-89.
-
2005: Hamaad Ali; Sosin Michael; Blann Andrew D; Patel Jeetesh; Lip Gregory Y H; MacFadyen Robert J
Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability.
Clinical cardiology 2005;28(12):570-6.
-
2005: Boos Christopher J; Goon Patrick K Y; Lip Gregory Y H
Circulating endothelial progenitor cells.
The New England journal of medicine 2005;353(24):2613-6; author reply 2613-6.
-
2005: Lip Gregory Y H; Varughese George I
Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links.
International journal of cardiology 2005;105(3):319-21.
-
2005: Boos Christopher J; Lip Gregory Y H
Biomarkers in atrial fibrillation: further observations on biologic plausibility, cause and effect.
Journal of thrombosis and thrombolysis 2005;20(3):189-90.
-
2005: Lee Kaeng W; Blann Andrew D; Lip Gregory Y H
Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes.
Thrombosis and haemostasis 2005;94(5):1077-83.
-
2005: Nadar Sunil K; Karalis Ioannis; Al Yemeni Eman; Blann Andrew D; Lip Gregory Y H
Plasma markers of angiogenesis in pregnancy induced hypertension.
Thrombosis and haemostasis 2005;94(5):1071-6.
-
2005: Lip Gregory Y H; Boos Christopher J
Ethnic differences in arterial responses, inflammation, and metabolic profiles: possible insights into ethnic differences in cardiovascular disease and stroke.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(11):2240-2.
-
2005: Felmeden Dirk C; Lip Gregory Y H
Endothelial function and its assessment.
Expert opinion on investigational drugs 2005;14(11):1319-36.
-
2005: Nadar Sunil K; Lip Gregory Y H; Lee Kaeng W; Blann Andrew D
Circulating endothelial cells in acute ischaemic stroke.
Thrombosis and haemostasis 2005;94(4):707-12.
-
2005: Freestone Bethan; Lip Gregory Y H; Chong Aun Yeong; Nadar Sunil; Lee Kaeng W; Blann Andrew D
Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.
Thrombosis and haemostasis 2005;94(4):702-6.
-
2005: Choudhury Anirban; Varughese George I; Lip Gregory Y H
Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?
Expert opinion on pharmacotherapy 2005;6(13):2193-207.
-
2005: Lee Kaeng W; Blann Andrew D; Lip Gregory Y H
Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation.
American heart journal 2005;150(4):756-66.
-
2005: Bhatia Gurbir S; Sosin Michael D; Khattak Fazal H; Davis Russell C; Lip Gregory Y H
Rheumatoid disease and ischaemic heart disease: insights from pathophysiology and vascular biology.
International journal of cardiology 2005;105(1):1-10.
-
2005: Tan Kiat T; Lip Gregory Y H
The potential role of platelet microparticles in atherosclerosis.
Thrombosis and haemostasis 2005;94(3):488-92.
-
2005: Tan Kiat T; Tayebjee Muzahir H; Macfadyen Robert J; Lip Gregory Y H; Blann Andrew D
Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation.
Platelets 2005;16(6):368-71.
-
2005: Schulman Sam; Lip Gregory Y H
Ximelagatran in the clinic: practical management of patients.
Seminars in vascular medicine 2005;5(3):301-7.
-
2005: Lim Hoong Sern; Lip Gregory Y H
Interleukin-15 in hypertension: further insights into inflammation and vascular disease.
American journal of hypertension 2005;18(8):1017-8.
-
2005: Tomson Joseph; Lip Gregory Y H
Blood pressure changes in acute haemorrhagic stroke.
Blood pressure monitoring 2005;10(4):197-9.
-
2005: Tayebjee Muzahir H; Lip Gregory Y H; Tan Kiat T; Patel Jeetesh V; Hughes Elizabeth A; MacFadyen Robert J
Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
The American journal of cardiology 2005;96(3):339-45.
-
2005: Boos Christopher J; Lip Gregory Y H
The role of inflammation in atrial fibrillation.
International journal of clinical practice 2005;59(8):870-2.
-
2005: Boos Christopher J; Lip Gregory Y H
Ximelagatran for stroke prevention in atrial fibrillation.
Expert review of cardiovascular therapy 2005;3(4):551-63.
-
2005: Tan Kiat T; Tayebjee Muzahir H; Macfadyen Robert J; Lip Gregory Y H
Relation of platelet activation to coronary angiographic severity and collateralization.
The American journal of cardiology 2005;96(2):208-10.
-
2005: Lane Deirdre A; Lip Gregory Y H; Beevers D Gareth
Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: the Birmingham Factory Screening Project.
Journal of hypertension 2005;23(7):1347-53.
-
2005: Varughese George I; Lip Gregory Y H
Is hypertension a prothrombotic state?
Current hypertension reports 2005;7(3):168-73.
-
2005: Brotman Daniel J; Girod John P; Garcia Mario J; Patel Jeetesh V; Gupta Manjula; Posch Amy; Saunders Sue; Lip Gregory Y H; Worley Sarah; Reddy Sethu
Effects of short-term glucocorticoids on cardiovascular biomarkers.
The Journal of clinical endocrinology and metabolism 2005;90(6):3202-8.
-
2005: Hamaad Ali; Sosin Mike; Lip Gregory Y H; MacFadyen Robert J
Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(3):183-7.
-
2005: Tayebjee Muzahir H; Lip Gregory Y H
Heterotopic heart transplantation.
International journal of cardiology 2005;101(2):311-2.
-
2005: Lip Gregory Y H; Chung Irene
Vascular endothelial growth factor and angiogenesis in heart failure.
Journal of cardiac failure 2005;11(4):285-7.
-
2005: Lim Hoong Sern; Lip Gregory Y H; Blann Andrew D
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
Atherosclerosis 2005;180(1):113-8.
-
2005: Schmidt-Lucke Caroline; Belgore Funmi; Reinhold Dirk; Ansorge Siegfried; Klein Helmut U; Schmidt-Lucke J André; Lip Gregory Y H
Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers.
International journal of cardiology 2005;100(2):207-12.
-
2005: López Francisca; Lee Kaeng W; Marín Francisco; Roldán Vanessa; Sogorb Francisco; Caturla Juan; Lip Gregory Y H
Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain.
International journal of cardiology 2005;100(1):151-4.
-
2005: Lim Hoong Sern; Patel Jeetesh V; Nadar Sunil; Hughes Elizabeth A; Lip Gregory Y H
Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects.
The American journal of cardiology 2005;95(7):905-8.
-
2005: Roldán Vanessa; Marín Francisco; Martínez Juan G; García-Herola Ana; Sogorb Francisco; Lip Gregory Y H
Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation.
The American journal of cardiology 2005;95(7):881-2.
-
2005: Tayebjee Muzahir H; Karalis Ioannis; Nadar Sunil K; Beevers D Gareth; MacFadyen Robert J; Lip Gregory Y H
Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
American journal of hypertension 2005;18(3):325-9.
-
2005: Conway Dwayne S G; Lip Gregory Y H
Atrial fibrillation, the prothrombotic state, inflammation, and gender.
The American journal of cardiology 2005;95(6):819.
-
2005: Nadar Sunil; Prasad Neeraj; Taylor Rod S; Lip Gregory Y H
Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta-analysis.
International journal of cardiology 2005;99(2):171-85.
-
2005: Varughese George I; Lip Gregory Y H
Goodbye mercury? Blood pressure measurement and its future.
Journal of the Royal Society of Medicine 2005;98(3):89-90.
-
2005: Blann Andrew D; Tan Kiat T; Tayebjee Muzahir H; Davagnanam Indran; Moss Mark; Lip Gregory Y H
Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.
Thrombosis and haemostasis 2005;93(3):578-83.
-
2005: Goyal Deepak; Macfadyen Robert J; Watson Robert D; Lip Gregory Y H
Ambulatory blood pressure monitoring in heart failure: a systematic review.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(2):149-56.
-
2005: Blann Andrew D; Woywodt Alexander; Bertolini Francesco; Bull Todd M; Buyon Jill P; Clancy Robert M; Haubitz Marion; Hebbel Robert P; Lip Gregory Y H; Mancuso Patrizia; Sampol Jose; Solovey Anna; Dignat-George Françoise
Circulating endothelial cells. Biomarker of vascular disease.
Thrombosis and haemostasis 2005;93(2):228-35.
-
2005: Goyal Deepak; Choudhury Anirban; Lip Gregory Y H
Thrombotic complications and thromboprophylaxis in breast and gynaecological malignancies.
Current opinion in obstetrics & gynecology 2005;17(1):13-20.
-
2005: Thrall Graham; Lip Gregory Y H
Exercise and the prothrombotic state: a paradox of cardiovascular prevention or an enhanced prothrombotic state?
Arteriosclerosis, thrombosis, and vascular biology 2005;25(2):265-6.
-
2005: Lim Hoong Sern; Felmeden Dirk; Lip Gregory Y H
Angiotensin II-mediated vascular inflammation: the balance between vascular endothelial growth factor and angiopoietins.
Hypertension 2005;45(2):e3.
-
2005: Bhatia Gurbir; Sosin Michael; Leahy John F; Connolly Derek L; Davis Russel C; Lip Gregory Y H
Hibernating myocardium in heart failure.
Expert review of cardiovascular therapy 2005;3(1):111-22.
-
2005: Bhatia Gurbir S; Sosin Michael D; Grindulis Karl A; Davis Russell C; Lip Gregory Y H
Rheumatoid disease and the heart: from epidemiology to echocardiography.
Expert opinion on investigational drugs 2005;14(1):65-76.
-
2005: Lee Kaeng W; Blann Andrew D; Lip Gregory Y H
High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
American journal of hypertension 2005;18(1):104-15.
-
2005: Iqbal M Bilal; Taneja Anil K; Lip Gregory Y H; Flather Marcus
Recent developments in atrial fibrillation.
BMJ (Clinical research ed.) 2005;330(7485):238-43.
-
2005: Marín Francisco; González-Conejero Rocío; Lee Kaeng W; Corral Javier; Roldán Vanessa; López Francisca; Sogorb Francisco; Caturla Juan; Lip Gregory Y H; Vicente Vicente
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
Journal of the American College of Cardiology 2005;45(1):25-9.
-
2005: Lane Deirdre; Lip Gregory Y H
Anti-thrombotic therapy for atrial fibrillation and patients' preferences for treatment.
Age and ageing 2005;34(1):1-3.
-
2005: Lee Kaeng W; Lip Gregory Y H; Tayebjee Muzahir; Foster William; Blann Andrew D
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes.
Blood 2005;105(2):526-32.
-
2005: Tan Kiat T; Lip Gregory Y H
The assessment of platelet activation in antiplatelet drug development.
Current medicinal chemistry 2005;12(26):3117-25.
-
2005: Freestone Bethan; Chong Aun Yeong; Lim Hoong Sern; Blann Andrew; Lip Gregory Y H
Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?
Annals of medicine 2005;37(5):365-72.
-
2005: Karalis Ioannis; Nadar Sunil K; Al Yemeni Eman; Blann Andrew D; Lip Gregory Y H
Platelet activation in pregnancy-induced hypertension.
Thrombosis research 2005;116(5):377-83.
-
2005: Roldán Vanessa; Marín Francisco; García-Herola Ana; Lip Gregory Y H
Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.
Thrombosis research 2005;116(4):321-5.
-
2005: Lip Gregory Y H; Chung Irene
Antiplatelet and anticoagulant therapy in patients with advanced heart failure.
Thrombosis research 2005;116(4):275-7.
-
2005: Tomson Joseph; Lip Gregory Y H
Peripheral arterial disease: a high risk - but neglected - disease population.
BMC cardiovascular disorders 2005;5(1):15.
-
2005: Chong Aun Yeong; Chin Bernard S P; Blann Andrew D; Lip Gregory Y H
Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm.
Thrombosis research 2005;116(2):181-3.
-
2005: Tan Kiat T; Tayebjee Muzahir H; Lynd Cheryl; Blann Andrew D; Lip Gregory Y H
Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
Annals of medicine 2005;37(1):61-6.
-
2005: Nadar Sunil K; Caine Graham J; Blann Andrew D; Lip Gregory Y H
Platelet adhesion in hypertension: application of a novel assay of platelet adhesion.
Annals of medicine 2005;37(1):55-60.
-
2005: Tayebjee Muzahir H; Lip Gregory Y H; MacFadyen Robert J
Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance.
Current medicinal chemistry 2005;12(8):917-25.
-
2005: Tomson Joseph; Os Ingrid; Lip Gregory Y H
Hormone replacement use and cardiovascular function and structure in postmenopausal women.
Blood pressure 2005;14(1):3-5.
-
2005: Lip Gregory Y H
Preventing stroke in atrial fibrillation: the SPORTIF programme.
Pathophysiology of haemostasis and thrombosis 2005;34 Suppl 1():25-30.
-
2005: Tan Kiat T; Lip Gregory Y H
Fondaparinux.
Current pharmaceutical design 2005;11(4):415-9.
-
2005: Tomson Joseph; Lip Gregory Y H
Blood pressure demographics: nature or nurture ... ... genes or environment?
BMC medicine 2005;3():3.
-
2005: Tayebjee Muzahir H; Lip Gregory Y H; Blann Andrew D; Macfadyen Robert J
Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2.
Thrombosis research 2005;115(3):205-10.
-
2005: Thrall Graham; Lip Gregory Y H
Haemoconcentration and the hypercoagulable state associated with mental stress.
Thrombosis research 2005;115(3):171-3.
-
2004: Bhatia Gurbir S; Lip Gregory Y H
Atrial fibrillation post-myocardial infarction: frequency, consequences, and management.
Current heart failure reports 2004;1(4):149-55.
-
2004: Lip Gregory Y H; Rothwell Peter; Sudlow Cathie
Stroke prevention.
Clinical evidence 2004;(12):253-84.
-
2004: Nadar Sunil K; Lip Gregory Y H; Blann Andrew D
Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke. The West Birmingham Stroke Project.
Thrombosis and haemostasis 2004;92(6):1342-8.
-
2004: Boos Christopher J; Lip Gregory Y H
Novel therapies for the prevention of stroke.
Expert opinion on investigational drugs 2004;13(12):1615-30.
-
2004: Lim Hoong Sern; Blann Andrew D; Chong Aun Yeong; Freestone Bethan; Lip Gregory Y H
Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.
Diabetes care 2004;27(12):2918-24.
-
2004: Sosin Michael D; Bhatia Gurbir S; Davis Russell C; Lip Gregory Y H
Heart failure--the importance of ethnicity.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2004;6(7):831-43.
-
2004: Lim Hoong Sern; Lip Gregory Y H; Blann Andrew D
Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension.
The Journal of clinical endocrinology and metabolism 2004;89(11):5377-81.
-
2004: Marín Francisco; Roldán Vanessa; Tello Antonio; Lip Gregory Y H
Genetic polymorphisms and thromoembolic risk in atrial fibrillation.
Journal of thrombosis and thrombolysis 2004;18(2):151-2.
-
2004: Hamaad Ali; Lip Gregory Y H; MacFadyen Robert J
Acute coronary syndromes presenting solely with heart failure symptoms: are they under recognised?
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2004;6(6):683-6.
-
2004: Conway Dwayne S G; Lip Gregory Y H
Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation.
European heart journal 2004;25(19):1761.
-
2004: Tayebjee Muzahir H; Lip Gregory Y H; MacFadyen Robert J
The unifying role of matrix metalloproteinases in atheroma and vascular stroke.
Stroke; a journal of cerebral circulation 2004;35(10):2239.
-
2004: Lee Kaeng W; Lip Gregory Y H; Blann Andrew D
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
Circulation 2004;110(16):2355-60.
-
2004: Conway Dwayne S g; Buggins Peter; Hughes Elizabeth; Lip Gregory Y H
Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation.
American heart journal 2004;148(3):462-6.
-
2004: Clagett G Patrick; Sobel Michael; Jackson Mark R; Lip Gregory Y H; Tangelder Marco; Verhaeghe Raymond
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest 2004;126(3 Suppl):609S-626S.
-
2004: Chong Aun Yeong; Blann Andrew D; Patel Jeetesh; Freestone Bethan; Hughes Elizabeth; Lip Gregory Y H
Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.
Circulation 2004;110(13):1794-8.
-
2004: Lim Hoong Sern; MacFadyen Robert J; Lip Gregory Y H
Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart.
Archives of internal medicine 2004;164(16):1737-48.
-
2004: Tayebjee Muzahir H; Nadar Sunil K; MacFadyen Robert J; Lip Gregory Y H
Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.
American journal of hypertension 2004;17(9):770-4.
-
2004: Tayebjee Muzahir H; Nadar Sunil; Blann Andrew D; Gareth Beevers D; MacFadyen Robert J; Lip Gregory Y H
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
American journal of hypertension 2004;17(9):764-9.
-
2004: Marín Francisco; Corral Javier; Roldán Vanessa; González-Conejero Rocío; del Rey María Luz; Sogorb Francisco; Lip Gregory Y H; Vicente Vicente
Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
Journal of molecular and cellular cardiology 2004;37(3):699-704.
-
2004: Choudhury Anirban; Lip Gregory Y H
Left ventricular systolic dysfunction and atrial fibrillation in older people in the community: the need for identification, as well as appropriate management.
Age and ageing 2004;33(5):434-6.
-
2004: Caine Graham J; Nadar Sunil K; Lip Gregory Y H; Stonelake Paul S; Blann Andrew D
Platelet adhesion in breast cancer: development and application of a novel assay.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(6):513-8.
-
2004: Lee Kaeng W; Hamaad Ali; MacFadyen Robert J; Lip Gregory Y H
Effects of dietary fat intake in sudden death: reduction of death with omega-3 fatty acids.
Current cardiology reports 2004;6(5):371-8.
-
2004: Conway Dwayne S G; Buggins Peter; Hughes Elizabeth; Lip Gregory Y H
Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation.
The American journal of cardiology 2004;94(4):508-10.
-
2004: Lim Hoong Sern; Hamaad Ali; Lip Gregory Y H
Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control.
Critical care (London, England) 2004;8(4):271-9.
-
2004: Sosin Michael D; Bhatia Gurbir S; Zarifis John; Davis Russell C; Lip Gregory Y H
An 8-year follow-up study of acute admissions with heart failure in a multiethnic population.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2004;6(5):669-72.
-
2004: Tayebjee Muzahir H; Lim H Sern; MacFadyen Robert J; Lip Gregory Y H
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy.
Diabetes care 2004;27(8):2049-51.
-
2004: Goyal Deepak; Choudhary Anirban; Lip Gregory Y H; MacFadyen Robert J
Diastolic heart failure: recognition, diagnosis and management.
Expert opinion on pharmacotherapy 2004;5(8):1745-54.
-
2004: Beevers D Gareth; Lip Gregory Y H; Blann Andrew D
Salt intake and Helicobacter pylori infection.
Journal of hypertension 2004;22(8):1475-7.
-
2004: Lim Hoong Sern; Patel Jeetesh V; Lip Gregory Y H
Metabolic syndrome: a definition in progress.
Circulation 2004;110(4):e35; author reply e35.
-
2004: Nadar Sunil K; Blann Andrew D; Kamath Sridhar; Beevers D Gareth; Lip Gregory Y H
Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Journal of the American College of Cardiology 2004;44(2):415-22.
-
2004: Caine Graham J; Lip Gregory Y H; Stonelake Paul S; Ryan Peter; Blann Andrew D
Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma.
Thrombosis and haemostasis 2004;92(1):185-90.
-
2004: Choudhury Anirban; Lip Gregory Y H
Antiarrhythmic drugs in atrial fibrillation: an overview of new agents, their mechanisms of action and potential clinical utility.
Expert opinion on investigational drugs 2004;13(7):841-55.
-
2004: Freestone Bethan; Lip Gregory Y H
Atrial fibrillation (acute).
Clinical evidence 2004;(11):76-97.
-
2004: Conway Dwayne S G; Lip Gregory Y H
Further insights into the prothrombotic state in mitral stenosis and atrial flutter.
Chest 2004;125(6):2361-2; author reply 2362-3.
-
2004: Conway Dwayne S G; Buggins Peter; Hughes Elizabeth; Lip Gregory Y H
Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation.
Journal of the American College of Cardiology 2004;43(11):2075-82.
-
2004: Conway Dwayne S G; Lip Gregory Y H
Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project).
The American journal of cardiology 2004;93(11):1422-5, A10.
-
2004: Conway Dwayne S G; Buggins Peter; Hughes Elizabeth; Lip Gregory Y H
Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation.
The American journal of cardiology 2004;93(11):1368-73, A6.
-
2004: Lim Hoong Sern; Blann Andrew D; Lip Gregory Y H
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
Circulation 2004;109(21):2524-8.
-
2004: Nadar Sunil; Lip Gregory Y H
Platelet activation in the hypertensive disorders of pregnancy.
Expert opinion on investigational drugs 2004;13(5):523-9.
-
2004: Lane Deirdre; Lip Gregory Y H; Carroll Douglas
Is depression following acute myocardial infarction an independent risk for mortality?
The American journal of cardiology 2004;93(10):1333-4.
-
2004: Spencer Charles G C; Martin Steven C; Felmeden Dirk C; Blann Andrew D; Beevers Gareth D; Lip Gregory Y H
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
International journal of cardiology 2004;94(2-3):293-300.
-
2004: Makin Andrew J; Blann Andrew D; Chung Natali A Y; Silverman Stanley H; Lip Gregory Y H
Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
European heart journal 2004;25(5):371-6.
-
2004: Lee Kaeng W; Lip Gregory Y H
Acute versus habitual exercise, thrombogenesis and exercise intensity.
Thrombosis and haemostasis 2004;91(3):416-9.
-
2004: Foster William; Lip Gregory Y H
Hormone replacement therapy and cardiovascular disease: does route of administration and formulation matter?
British journal of haematology 2004;124(6):836-40.
-
2004: Chong Aun Yeong; Caine Graham J; Freestone Bethan; Blann Andrew D; Lip Gregory Y H
Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
Journal of the American College of Cardiology 2004;43(3):423-8.
-
2004: Freestone Bethan; Lip Gregory Y H
Tedisamil: a new novel antiarrhythmic.
Expert opinion on investigational drugs 2004;13(2):151-60.
-
2004: Brotman Daniel J; Deitcher Steven R; Lip Gregory Y H; Matzdorff Axel C
Virchow's triad revisited.
Southern medical journal 2004;97(2):213-4.
-
2004: Bacon Simon L; Ring Christopher; Lip Gregory Y H; Carroll Douglas
Increases in lipids and immune cells in response to exercise and mental stress in patients with suspected coronary artery disease: effects of adjustment for shifts in plasma volume.
Biological psychology 2004;65(3):237-50.
-
2004: Landray Martin J; Wheeler David C; Lip Gregory Y H; Newman David J; Blann Andrew D; McGlynn Fiona J; Ball Simon; Townend John N; Baigent Colin
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(2):244-53.
-
2004: Marín Francisco; Roldán Vanessa; Climent Vicente; Lip Gregory Y H
Matrix metalloproteinases in atrial fibrillation.
Journal of the American College of Cardiology 2004;43(1):152; author reply 152-3.
-
2004: Sosin Michael; Davis Russell C; Lip Gregory Y H
Mortality in congestive heart failure complicated by atrial fibrillation.
European heart journal 2004;25(1):97-8; author reply 98.
-
2004: Nadar Sunil; Blann Andrew D; Lip Gregory Y H
Antihypertensive therapy and endothelial function.
Current pharmaceutical design 2004;10(29):3607-14.
-
2004: Nadar Sunil; Blann Andrew D; Lip Gregory Y H
Endothelial dysfunction: methods of assessment and application to hypertension.
Current pharmaceutical design 2004;10(29):3591-605.
-
2004: Sosin Michael D; Bhatia Gurbir S; Lip Gregory Y H; Davis Russell C
Drug development and the importance of ethnicity: lessons from heart failure management and implications for hypertension.
Current pharmaceutical design 2004;10(29):3569-77.
-
2004: Nadar Sunil; Blann Andrew D; Lip Gregory Y H
Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy.
Annals of medicine 2004;36(7):552-7.
-
2004: Hamaad Ali; Lip Gregory Y H; MacFadyen Robert J
Heart rate variability estimates of autonomic tone: relationship to mapping pathological and procedural stress responses in coronary disease.
Annals of medicine 2004;36(6):448-61.
-
2004: Lip Gregory Y H; Blann Andrew D
Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad'.
Annals of medicine 2004;36(2):119-25.
-
2004: Nadar Sunil K; Al Yemeni Eman; Blann Andrew D; Lip Gregory Y H
Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
Thrombosis research 2004;113(2):123-8.
-
2003: Freestone Bethan; Lip Gregory Y H; Rothwell Peter; Sudlow Cathie
Stroke prevention.
Clinical evidence 2003;(10):246-72.
-
2003: Freestone Bethan; Lip Gregory Y H
Atrial fibrillation (acute).
Clinical evidence 2003;(10):76-94.
-
2003: Tan Kiat T; Lip Gregory Y H
Atrial fibrillation: should we target platelets or the coagulation pathway?
Cardiac electrophysiology review 2003;7(4):370-1.
-
2003: Chung Irene; Lip Gregory Y H
White coat hypertension: not so benign after all?
Journal of human hypertension 2003;17(12):807-9.
-
2003: Conway Dwayne S G; Lip Gregory Y H
Ethnicity in relation to atrial fibrillation and stroke (the West Birmingham Stroke Project).
The American journal of cardiology 2003;92(12):1476-9.
-
2003: Lim Hoong Sern; Lip Gregory Y H
Is angiotensin receptor blockade antithrombotic?
Archives of internal medicine 2003;163(22):2790-1; author reply 2792-3.
-
2003: Alfonso Fernando; Tayebjee Muzahir H; Lip Gregory Y H
Restenosis after coronary stenting: the 'gender paradox'.
European heart journal 2003;24(24):2239.
-
2003: Blann Andrew D; Nadar Sunil K; Lip Gregory Y H
The adhesion molecule P-selectin and cardiovascular disease.
European heart journal 2003;24(24):2166-79.
-
2003: Roldán Vanessa; Marín Francisco; Lip Gregory Y H; Blann Andrew D
Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature.
Thrombosis and haemostasis 2003;90(6):1007-20.
-
2003: Tayebjee Muzahir H; Lip Gregory Y H
Psychosocial functioning of adults with congenital heart disease: a neglected area.
European heart journal 2003;24(23):2159; author reply 2159-60.
-
2003: Lane Deirdre; Carroll Douglas; Lip Gregory Y H
Anxiety, depression, and prognosis after myocardial infarction: is there a causal association?
Journal of the American College of Cardiology 2003;42(10):1808-10.
-
2003: Tan Kiat T; Lip Gregory Y H
Red vs white thrombi: treating the right clot is crucial.
Archives of internal medicine 2003;163(20):2534-5; author reply 2535.
-
2003: Tan Kiat Tsong; Lip Gregory Y H
Platelets, atherosclerosis and the endothelium: new therapeutic targets?
Expert opinion on investigational drugs 2003;12(11):1765-76.
-
2003: Chong Aun Yeong; Lip Gregory Y H
LIFE: losartan versus atenolol.
Lancet 2003;362(9393):1416.
-
2003: Lee Kaeng W; Lip Gregory Y H
Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review.
Archives of internal medicine 2003;163(19):2368-92.
-
2003: Caine Graham J; Stonelake Paul S; Rea Daniel; Lip Gregory Y H
Coagulopathic complications in breast cancer.
Cancer 2003;98(8):1578-86.
-
2003: Caine Graham J; Lip Gregory Y H
Thromboembolism associated with new anti-cancer treatment strategies in combination with conventional chemotherapy: new drugs, old risks?
Thrombosis and haemostasis 2003;90(4):567-9.
-
2003: Chin Bernard S P; Gibbs Christopher R; Blann Andrew D; Lip Gregory Y H
Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
Clinical science (London, England : 1979) 2003;105(4):507-12.
-
2003: Chung Irene; Lip Gregory Y H
Virchow's triad revisited: blood constituents.
Pathophysiology of haemostasis and thrombosis 2003;33(5-6):449-54.
-
2003: Choudhury Anirban; Lip Gregory Y H
Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice.
Pathophysiology of haemostasis and thrombosis 2003;33(5-6):282-9.
-
2003: Nadar Sunil; Lip Gregory Y H; Beevers D Gareth
Primary hyperaldosteronism.
Annals of clinical biochemistry 2003;40(Pt 5):439-52.
-
2003: Jolly Kate; Lip Gregory Y H; Sandercock Josie; Greenfield Sheila M; Raftery James P; Mant Jonathan; Taylor Rod; Lane Deirdre; Lee Kaeng Wai; Stevens A J
Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263].
BMC cardiovascular disorders 2003;3():10.
-
2003: Chin Bernard S P; Conway Dwayne S G; Chung Natalie A Y; Blann Andrew D; Gibbs Christopher R; Lip Gregory Y H
Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(6):515-21.
-
2003: Nadar Sunil; Lip Gregory Y H
Homocysteine and the risk of stroke and thromboembolism in atrial fibrillation: an uncertain role.
Stroke; a journal of cerebral circulation 2003;34(9):e143; author reply e143-5.
-
2003: Mant Jonathan W F; Richards Suzanne H; Hobbs F D Richard; Fitzmaurice David; Lip Gregory Y H; Murray Ellen; Banting Miriam; Fletcher Kate; Rahman Joy; Allan Teresa; Raftery James; Bryan Stirling;
Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269].
BMC cardiovascular disorders 2003;3():9.
-
2003: Chong Aun-Yeong; Rajaratnam Ratna; Hussein Nur Run; Lip Gregory Y H
Heart failure in a multiethnic population in Kuala Lumpur, Malaysia.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(4):569-74.
-
2003: Felmeden Dirk C; Spencer Charles G C; Chung Natali A Y; Belgore Funmi M; Blann Andrew D; Beevers D Gareth; Lip Gregory Y H
Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
The American journal of cardiology 2003;92(4):400-5.
-
2003: Roldán Vanessa; Marín Francisco; Blann Andrew D; García Amaya; Marco Pascual; Sogorb Francisco; Lip Gregory Y H
Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.
European heart journal 2003;24(14):1373-80.
-
2003: Nadar Sunil; Blann Andrew; Lip Gregory Y H
Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(5):513-4.
-
2003: Tayebjee Muzahir H; Lip Gregory Y H
Fibrin D-dimer levels in atrial fibrillation as an index of thrombogenesis: a possible test to exclude left atrial thrombus?
The American journal of cardiology 2003;92(1):47-9.
-
2003: Conway Dwayne S G; Pearce Lesly A; Chin Bernard S P; Hart Robert G; Lip Gregory Y H
Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.
Circulation 2003;107(25):3141-5.
-
2003: Tan Kiat T; Lip Gregory Y H; Blann Andrew D
Post-stroke inflammatory response: effects of stroke evolution and outcome.
Current atherosclerosis reports 2003;5(4):245-51.
-
2003: Blann Andrew D; Nadar Sunil; Lip Gregory Y H
Pharmacological modulation of platelet function in hypertension.
Hypertension 2003;42(1):1-7.
-
2003: Lim Hoong Sern; Lip Gregory Y H
Diabetes, the renin-angiotensin system and heart disease.
Current vascular pharmacology 2003;1(2):225-38.
-
2003: Blann Andrew D; Lip Gregory Y H
Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(4):335-40.
-
2003: Caine Graham J; Lip Gregory Y H
Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?
Archives of internal medicine 2003;163(10):1243-4; author reply 1244.
-
2003: Nadar Sunil; Lip Gregory Y H
Hypertension and the prothrombotic state.
Journal of the American College of Cardiology 2003;41(10):1847; author reply 1847.
-
2003: Caine Graham J; Lip Gregory Y H
Validity of D-dimer tests for pulmonary embolism: better to diagnose or exclude?
Annals of emergency medicine 2003;41(5):756; author reply 756-7.
-
2003: Hamaad Ali; Lip Gregory Y H
Intravenous water-soluble amiodarone improved 24-hour survival in incessant ventricular tachycardia.
ACP journal club 2003;138(3):62.
-
2003: Nadar Sunil; Lim Hoong Sern; Lip Gregory Y H
Implications of the LIFE trial.
Expert opinion on investigational drugs 2003;12(5):871-7.
-
2003: Hamaad Ali; Tayebjee Muzahir H; Lip Gregory Y H
The METHRO trials.
Expert opinion on investigational drugs 2003;12(5):865-70.
-
2003: Tan Kiat Tsong; Makin Andrew; Lip Gregory Y H
Factor X inhibitors.
Expert opinion on investigational drugs 2003;12(5):799-804.
-
2003: Marín Francisco; Roldán Vanessa; Climent Vicente; Garcia Amaya; Marco Pascual; Lip Gregory Y H
Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
Stroke; a journal of cerebral circulation 2003;34(5):1181-6.
-
2003: Nadar Sunil; Begum Nazneen; Kaur Bhupinder; Sandhu Sukhpreet; Lip Gregory Y H
Patients' understanding of anticoagulant therapy in a multiethnic population.
Journal of the Royal Society of Medicine 2003;96(4):175-9.
-
2003: Makin Andrew J; Chung Natalia A Y; Silverman Stanley H; Lip Gregory Y H
Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?
Clinical science (London, England : 1979) 2003;104(4):397-404.
-
2003: Makin Andrew J; Chung Natali A Y; Silverman Stanley H; Moss Mark S; Lip Gregory Y H
Indices of thrombogenesis, endothelial damage and platelet function following percutaneous peripheral artery angiography and angioplasty for peripheral vascular disease.
Pathophysiology of haemostasis and thrombosis 2003;33(2):102-8.
-
2003: Marín Francisco; Roldán Vanessa; Lip Gregory Y H
Fibrinolytic function and atrial fibrillation.
Thrombosis research 2003;109(5-6):233-40.
-
2003: Chin Bernard S P; Langford Nigel J; Nuttall Sarah L; Gibbs Christopher R; Blann Andrew D; Lip Gregory Y H
Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(2):171-4.
-
2003: Lim Hoong Sern; Lip Gregory Y H
A case of breathlessness.
The Practitioner 2003;247(1644):199-200, 204-7.
-
2003: Freestone Bethan; Lip Gregory Y H
Anticoagulation uptake in emergency department patients with atrial fibrillation.
Stroke; a journal of cerebral circulation 2003;34(3):591; author reply 591.
-
2003: Felmeden Dirk C; Spencer Charles G C; Blann Andrew D; Beevers D Gareth; Lip Gregory Y H
Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment.
Hypertension 2003;41(3):528-33.
-
2003: Conway Dwayne S G; Heeringa Jan; Van Der Kuip Deirdre A M; Chin Bernard S P; Hofman Albert; Witteman Jacqueline C M; Lip Gregory Y H
Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study.
Stroke; a journal of cerebral circulation 2003;34(2):413-7.
-
2003: Lip Gregory Y H
Hypertension, platelets, and the endothelium: the "thrombotic paradox" of hypertension (or "Birmingham paradox") revisited.
Hypertension 2003;41(2):199-200.
-
2003: Lip Gregory Y H; Beevers D Gareth
Alcohol and cardiovascular disease--more than one paradox to consider. Alcohol and hypertension--does it matter? (no!).
Journal of cardiovascular risk 2003;10(1):11-4.
-
2003: Freestone Bethan; Lip Gregory Y H
Ethnicity and arrhythmias.
Cardiac electrophysiology review 2003;7(1):92-5.
-
2003: Caine Graham J; Lip Gregory Y H
D-dimer tests for assessment of patients with suspected pulmonary embolism.
Archives of internal medicine 2003;163(2):243.
-
2003: Blann Andrew D; Fitzmaurice David A; Lip Gregory Y H
Anticoagulation in hospitals and general practice.
BMJ (Clinical research ed.) 2003;326(7381):153-6.
-
2003: Caine Graham J; Blann Andrew D; Stonelake Paul S; Kehoe Sean T; Lip Gregory Y H
Tamoxifen for breast-cancer prevention.
Lancet 2003;361(9352):177-8; author reply 178.
-
2003: Jilma Bernd; Kamath Sridhar; Lip Gregory Y H
ABC of antithrombotic therapy: Antithrombotic therapy in special circumstances. II-In children, thrombophilia, and miscellaneous conditions.
BMJ (Clinical research ed.) 2003;326(7380):93-6.
-
2003: Felmeden Dirk C; Spencer Charles G C; Belgore Funmi M; Blann Andrew D; Beevers D Gareth; Lip Gregory Y H
Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.
American journal of hypertension 2003;16(1):11-20.
-
2003: Jilma Bernd; Kamath Sridhar; Lip Gregory Y H
Antithrombotic therapy in special circumstances. I--pregnancy and cancer.
BMJ (Clinical research ed.) 2003;326(7379):37-40.
-
2003: Hamaad Ali; Lip Gregory Y H; MacFadyen Robert J
Unheralded sudden cardiac death: do autonomic tone and thrombosis interact as key factors in aetiology?
Annals of medicine 2003;35(8):592-604.
-
2003: Makin Andrew J; Chung Natali A Y; Silverman Stanley H; Lip Gregory Y H
Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease. Relationship to ethnicity and disease severity.
Thrombosis research 2003;111(4-5):221-6.
-
2003: Lip Gregory Y H
The prothrombotic state in atrial fibrillation: the atrium, the endothelium... And tissue factor?
Thrombosis research 2003;111(3):133-5.
-
2003: Nadar Sunil; Lip Gregory Y H
The prothrombotic state in hypertension and the effects of antihypertensive treatment.
Current pharmaceutical design 2003;9(21):1715-32.
-
2003: MacFadyen Robert J; Lip Gregory Y H; Davis Russell
Hypertension to heart failure: new developmental strategies do not cross a clinical and therapeutic divide.
Current pharmaceutical design 2003;9(21):1665-78.
-
2003: Svensson Staffan; Lip Gregory Y H
Patient perceptions of hypertension and its treatment.
Blood pressure 2003;12(1):5-6.
-
2002: Lane Deirdre; Carroll Douglas; Ring Christopher; Beevers D Gareth; Lip Gregory Y H
In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction.
International journal of epidemiology 2002;31(6):1179-82.
-
2002: Connolly Derek L; Lip Gregory Y H; Chin Bernard S P
Antithrombotic strategies in acute coronary syndromes and percutaneous coronary interventions.
BMJ (Clinical research ed.) 2002;325(7377):1404-7.
-
2002: Meinertz Thomas; Lip Gregory Y H; Lombardi Fedrico; Sadowski Zigmunt P; Kalsch Brigitte; Camez Anne; Hewkin Ann; Eberle Siegfried;
Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).
The American journal of cardiology 2002;90(12):1300-6.
-
2002: Watson Robert D S; Chin Bernard S P; Lip Gregory Y H
Antithrombotic therapy in acute coronary syndromes.
BMJ (Clinical research ed.) 2002;325(7376):1348-51.
-
2002: Chin Bernard S P; Chung Natali A Y; Gibbs Christopher R; Blann Andrew D; Lip Gregory Y H
Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure.
The American journal of cardiology 2002;90(11):1258-60.
-
2002: Lip Gregory Y H; Chin Bernard S P; Prasad Neeraj
ABC of antithrombotic therapy: Antithrombotic therapy in myocardial infarction and stable angina.
BMJ (Clinical research ed.) 2002;325(7375):1287-9.
-
2002: Goldsmith Ira; Turpie Alexander G G; Lip Gregory Y H
Valvar heart disease and prosthetic heart valves.
BMJ (Clinical research ed.) 2002;325(7374):1228-31.
-
2002: Nadar Sunil; Lip Gregory Y H
Ongoing trials involving angiotensin-converting enzyme inhibitors.
Expert opinion on investigational drugs 2002;11(11):1633-43.
-
2002: Lip Gregory Y H; Kamath Sridhar; Hart Robert G
ABC of antithrombotic therapy: Antithrombotic therapy for cerebrovascular disorders.
BMJ (Clinical research ed.) 2002;325(7373):1161-3.
-
2002: Makin Andrew J; Silverman Stanley H; Lip Gregory Y H
Antithrombotic therapy in peripheral vascular disease.
BMJ (Clinical research ed.) 2002;325(7372):1101-4.
-
2002: Kamath Sridar; Lip Gregory Y H
Atrial fibrillation in the elderly: anticoagulation strategies and indications in the very elderly.
The American journal of geriatric cardiology 2002;11(6):357-62; quiz 363-4.
-
2002: Lip Gregory Y H; Hart Robert G; Conway Dwayne S G
Antithrombotic therapy for atrial fibrillation.
BMJ (Clinical research ed.) 2002;325(7371):1022-5.
-
2002: Caine Graham J; Stonelake Paul S; Lip Gregory Y H; Kehoe Sean T
The hypercoagulable state of malignancy: pathogenesis and current debate.
Neoplasia (New York, N.Y.) 2002;4(6):465-73.
-
2002: Tin Lwin Lwin; Beevers D Gareth; Lip Gregory Y H
Hypertension, left ventricular hypertrophy, and sudden death.
Current cardiology reports 2002;4(6):449-57.
-
2002: Turpie Alexander G G; Chin Bernard S P; Lip Gregory Y H
ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies.
BMJ (Clinical research ed.) 2002;325(7370):948-50.
-
2002: Turpie Alexander G G; Chin Bernard S P; Lip Gregory Y H
Venous thromboembolism: pathophysiology, clinical features, and prevention.
BMJ (Clinical research ed.) 2002;325(7369):887-90.
-
2002: Fitzmaurice David A; Blann Andrew D; Lip Gregory Y H
Bleeding risks of antithrombotic therapy.
BMJ (Clinical research ed.) 2002;325(7368):828-31.
-
2002: Caine Graham J; Lip Gregory Y H
Anticoagulants as anticancer agents?
The lancet oncology 2002;3(10):591-2.
-
2002: Conway Dwayne S G; Pearce Lesly A; Chin Bernard S P; Hart Robert G; Lip Gregory Y H
Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.
Circulation 2002;106(15):1962-7.
-
2002: Blann Andrew D; Landray Martin J; Lip Gregory Y H
ABC of antithrombotic therapy: An overview of antithrombotic therapy.
BMJ (Clinical research ed.) 2002;325(7367):762-5.
-
2002: Chung Natali A Y; Belgore Funmi; Li-Saw-Hee Foo Leong; Conway Dwayne S G; Blann Andrew D; Lip Gregory Y H
Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?
Stroke; a journal of cerebral circulation 2002;33(9):2187-91.
-
2002: Blann Andrew D; Ridker Paul M; Lip Gregory Y H
Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology?
Stroke; a journal of cerebral circulation 2002;33(9):2141-3.
-
2002: Blann A D; McCollum C N; Lip G Y
Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2002;13(6):513-8.
-
2002: Lee Kaeng W; Lip Gregory Y H
Airborne occupational exposure and ABO phenotype: an example of gene-environment interaction in ischaemic heart disease?
Journal of cardiovascular risk 2002;9(4):179-82.
-
2002: Kamath Sridhar; Blann Andrew D; Chin Bernard S P; Lip Gregory Y H
A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
Journal of the American College of Cardiology 2002;40(3):484-90.
-
2002: Makin Andrew J; Chung Natali A Y; Silverman Stanley H; Lip Gregory Y H
Alterations of thrombogenesis, endothelial damage and oxidative stress with reperfusion during femoral artery bypass surgery for peripheral vascular disease.
Pathophysiology of haemostasis and thrombosis 2002;32(4):158-64.
-
2002: Nadar Sunil; Beevers D Gareth; Lip Gregory Y H
Hypertension and renal failure.
Clinical medicine (London, England) 2002;2(4):378-9.
-
2002: Spencer Charles G C; Gurney David; Blann Andrew D; Beevers D Gareth; Lip Gregory Y H;
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Hypertension 2002;40(1):61-6.
-
2002: Gurney David; Lip Gregory Y H; Blann Andrew D
A reliable plasma marker of platelet activation: does it exist?
American journal of hematology 2002;70(2):139-44.
-
2002: Nadar Sunil; Lip Gregory Y H
Cardiomyopathy in practice.
The Practitioner 2002;246(1635):416, 420-7.
-
2002: Marco Pascual; Marín Francisco; García Amaya; Roldán Vanessa; Lip Gregory Y H
Do protein Z levels influence the prothrombotic state in atrial fibrillation?
Thrombosis research 2002;106(4-5):269-70.
-
2002: Kamath Sridhar; Blann Andrew D; Caine Graham J; Gurney David; Chin Bernard S P; Lip Gregory Y H
Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation.
Stroke; a journal of cerebral circulation 2002;33(5):1237-42.
-
2002: Freestone Bethan; Lip Gregory Y H
Prevalence and risk factors of silent brain infarcts in the population.
Stroke; a journal of cerebral circulation 2002;33(5):1179-80; author reply 1179-80.
-
2002: Lee Kaeng W; Felmeden Dirk C; Lip Gregory Y H
Statins and the assessment of endothelial function.
Journal of internal medicine 2002;251(5):452-3; author reply 453-4.
-
2002: Lee Kaeng W; Felmeden Dirk C; Lip Gregory Y H
Lipid lowering and the assessment of endothelial function.
Cardiovascular research 2002;54(1):191-2; author reply 193-4.
-
2002: Freestone Bethan; Lip Gregory Y H
Risk factors for mortality in acute myocardial infarction.
Lancet 2002;359(9313):1252.
-
2002: MacMahon Kenneth M A; Lip Gregory Y H
Psychological factors in heart failure: a review of the literature.
Archives of internal medicine 2002;162(5):509-16.
-
2002: Blann Andrew D; Lip Gregory Y H
Soluble adhesion molecules and coronary heart disease.
Lancet 2002;359(9305):525-6; author reply 526-7.
-
2002: Blann Andrew D; Belgore Funmi M; McCollum Charles N; Silverman Stanley; Lip Peck Lin; Lip Gregory Y H
Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes.
Clinical science (London, England : 1979) 2002;102(2):187-94.
-
2002: Freestone Bethan; Lip Gregory Y H
Antiarrhythmics in atrial fibrillation.
Current opinion in investigational drugs (London, England : 2000) 2002;3(1):84-8.
-
2002: Lip Gregory Y H; Chin Bernard S P; Blann Andrew D
Cancer and the prothrombotic state.
The lancet oncology 2002;3(1):27-34.
-
2002: Lip Gregory Y H; Kamath Sridhar; Jafri Marian; Mohammed Afzal; Bareford David
Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project.
Stroke; a journal of cerebral circulation 2002;33(1):238-42.
-
2002: Chong Aun-Yeong; Lip Gregory Y H
Hormone replacement therapy and cardiovascular risk.
Treatments in endocrinology 2002;1(2):95-103.
-
2001: Dhanjal T S; Lal M; Haynes R; Lip G
A comparison of cardiovascular risk factors among Indo-Asian and caucasian patients admitted with acute myocardial infarction in Kuala Lumpur, Malaysia and Birmingham, England.
International journal of clinical practice 2001;55(10):665-8.
-
2001: Beevers D G; Lip G Y
The protective effect of blocking angiotensin in both type I and type II diabetics with nephropathy.
Journal of human hypertension 2001;15(12):837-9.
-
2001: Lip G Y; Beevers D G
ACE inhibitors in vascular disease: some PROGRESS, more HOPE.
Journal of human hypertension 2001;15(12):833-5.
-
2001: Lip G Y; Hee F L
Paroxysmal atrial fibrillation.
QJM : monthly journal of the Association of Physicians 2001;94(12):665-78.
-
2001: Kamath S; Blann A D; Lip G Y
Platelets and atrial fibrillation.
European heart journal 2001;22(24):2233-42.
-
2001: Gibbs C R; Blann A D; Edmunds E; Watson R D; Lip G Y
Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm.
Clinical cardiology 2001;24(11):724-9.
-
2001: Langman C M; Lyons A C; Lip G Y
Perceptions and behaviour of hypertensive patients: a divine intervention or a case for Hippocrates?
Journal of human hypertension 2001;15(11):751-4.
-
2001: Felmeden D C; Lip G Y; Beevers G
Calcium antagonists in diabetic hypertension.
Diabetes, obesity & metabolism 2001;3(5):311-8.
-
2001: Chin B S; Futaba K; Jethwa A; Lip G Y
The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population.
International journal of clinical practice 2001;55(8):515-8.
-
2001: Lip G Y
Alcohol and the heart.
The Practitioner 2001;245(1627):808-10, 812, 814 passim.
-
2001: Lane D; Carroll D; Ring C; Beevers D G; Lip G Y
Predictors of attendance at cardiac rehabilitation after myocardial infarction.
Journal of psychosomatic research 2001;51(3):497-501.
-
2001: Blann A D; Lanza F; Galajda P; Gurney D; Moog S; Cazenave J P; Lip G Y
Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis--the influence of aspirin and cigarette smoking.
Thrombosis and haemostasis 2001;86(3):777-83.
-
2001: Spencer C G; Lip G Y
Left internal mammary graft stenosis and restenosis following angioplasty and stenting.
Heart (British Cardiac Society) 2001;86(3):E9.
-
2001: Li-Saw-Hee F L; Blann A D; Gurney D; Lip G Y
Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
European heart journal 2001;22(18):1741-7.
-
2001: Kamath S; Blann A D; Lip G Y
Platelet activation: assessment and quantification.
European heart journal 2001;22(17):1561-71.
-
2001: Kamath S; Lip G Y
YM-337. Yamanouchi.
Current opinion in investigational drugs (London, England : 2000) 2001;2(8):1093-6.
-
2001: Spencer C G; Beevers D G; Lip G Y;
Haemorheological, endothelial and platelet function in subjects with hypertension: relationship to cardiovascular risk and influence of antihypertensive treatment.
Journal of human hypertension 2001;15 Suppl 1():S39-42.
-
2001: Lip G Y; Edmunds E; Hee F L; Blann A D; Beevers D G
A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension.
American journal of hypertension 2001;14(8 Pt 1):823-8.
-
2001: Chin B S; Lip G Y
New pharmacological strategies for the treatment of heart failure.
Current opinion in investigational drugs (London, England : 2000) 2001;2(7):923-8.
-
2001: Lydakis C; Beevers M; Beevers D G; Lip G Y
The prevalence of pre-eclampsia and obstetric outcome in pregnancies of normotensive and hypertensive women attending a hospital specialist clinic.
International journal of clinical practice 2001;55(6):361-7.
-
2001: Lip G Y; Edmunds E; Martin S C; Jones A F; Blann A D; Beevers D G
A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damage.
American journal of hypertension 2001;14(7 Pt 1):627-31.
-
2001: Makin A; Lip G Y; Silverman S; Beevers D G
Peripheral vascular disease and hypertension: a forgotten association?
Journal of human hypertension 2001;15(7):447-54.
-
2001: Chung N A; Lip G Y
Right atrial function in hypertension.
Journal of human hypertension 2001;15(7):439-41.
-
2001: Lane D A; Lip G Y
Ethnic differences in hypertension and blood pressure control in the UK.
QJM : monthly journal of the Association of Physicians 2001;94(7):391-6.
-
2001: Blann A D; Gurney D; Hughes E; Buggins P; Silverman S H; Lip G Y
Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease.
The American journal of cardiology 2001;88(1):A7-8, 89-92.
-
2001: Lip G Y; Blann A D; Farooqi I S; Zarifis J; Sagar G; Beevers D G
Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: the West Birmingham Stroke Project.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(4):307-15.
-
2001: Chin B; Spencer C G; Lip G Y
Unstable angina following acute MI in a patient with bilateral coronary artery fistulae: an unusual presentation of coronary steal?
International journal of clinical practice 2001;55(5):342-3.
-
2001: Lip G Y; Beevers M; Beevers D G; Dillon M J
The measurement of blood pressure and the detection of hypertension in children and adolescents.
Journal of human hypertension 2001;15(6):419-23.
-
2001: Edmunds E; Landray M J; Li-Saw-Hee F L; Hughes B A; Beevers D G; Lip G Y
Dyslipidaemia in patients with malignant-phase hypertension.
QJM : monthly journal of the Association of Physicians 2001;94(6):327-32.
-
2001: Felmeden D C; Lip G Y
Resistant hypertension and the Birmingham Hypertension Square.
Current hypertension reports 2001;3(3):203-8.
-
2001: Li-Saw-Hee F L; Beevers D G; Lip G Y
Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial.
International journal of cardiology 2001;78(3):241-6.
-
2001: Conway D; Lip G Y
Case book: palpitations.
The Practitioner 2001;245(1622):393-6, 398, 401.
-
2001: Blann A D; Belgore F M; Constans J; Conri C; Lip G Y
Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate.
The American journal of cardiology 2001;87(10):1160-3.
-
2001: Li-Saw-Hee F L; Blann A D; Edmunds E; Gibbs C R; Lip G Y
Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation.
Clinical cardiology 2001;24(5):409-14.
-
2001: Belgore F M; Blann A D; Lip G Y
Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
Clinical science (London, England : 1979) 2001;100(5):567-75.
-
2001: Conway D S; Lip G Y
Helicobacter pylori as the cause of coronary artery restenosis following angioplasty--is the way to a man's heart disease through his stomach?
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2001;33(3):214-6.
-
2001: Conway D; Lip G Y
The ECG and left ventricular hypertrophy in primary care hypertensives.
Journal of human hypertension 2001;15(4):215-7.
-
2001: Lip P L; Blann A D; Hope-Ross M; Gibson J M; Lip G Y
Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.
Ophthalmology 2001;108(4):705-10.
-
2001: Gibbs C R; Blann A D; Watson R D; Lip G Y
Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
Circulation 2001;103(13):1746-51.
-
2001: Lip G Y; Edmunds E; Beevers D G
Should patients with hypertension receive antithrombotic therapy?
Journal of internal medicine 2001;249(3):205-14.
-
2001: Belgore F M; Blann A D; Li-Saw-Hee F L; Beevers D G; Lip G Y
Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension.
The American journal of cardiology 2001;87(6):805-7, A9.
-
2001: Chin B S; Lip G Y
Blockade of the renin-angiotensin-aldosterone system with combination angiotensin receptor antagonist and ACE inhibitor therapy: observations from Val-HeFT and CALM.
Journal of human hypertension 2001;15(2):89-92.
-
2001: Lip G Y; Beevers D G
Calcium channel blockers in hypertension: the debate reawakens.
Journal of human hypertension 2001;15(2):85-7.
-
2001: Conway D S; Lip G Y
New antiarrhythmic agents for atrial fibrillation.
Current opinion in investigational drugs (London, England : 2000) 2001;2(1):87-92.
-
2001: Belgore F M; Lip G Y; Bareford D; Wadley M; Stonelake P; Blann A D
Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancer.
American journal of hematology 2001;66(1):59-61.
-
2001: Blann A D; Gurney D; Wadley M; Bareford D; Stonelake P; Lip G Y
Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(1):43-50.
-
2001: Goldsmith I R; Blann A D; Patel R L; Lip G Y
Effect of aortic valve replacement on plasma soluble P-selectin, von Willebrand factor, and fibrinogen.
The American journal of cardiology 2001;87(1):107-10, A9.
-
2001: Lip G Y; Gibbs C R
Anticoagulation for heart failure in sinus rhythm.
Cochrane database of systematic reviews (Online) 2001;(4):CD003336.
-
2001: Lip G Y; Gibbs C R
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.
Cochrane database of systematic reviews (Online) 2001;(4):CD003333.
-
2000: Chin B; Lip G Y
Cariporide Aventis.
Current opinion in investigational drugs (London, England : 2000) 2000;1(3):340-6.
-
2000: Lane D; Carroll D; Ring C; Beevers D G; Lip G Y
Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction?
QJM : monthly journal of the Association of Physicians 2000;93(11):739-44.
-
2000: Goldsmith I; Kumar P; Carter P; Blann A D; Patel R L; Lip G Y
Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study.
American heart journal 2000;140(5):777-84.
-
2000: Felmeden D C; Lip G Y
Myocardial bridging.
International journal of clinical practice 2000;54(8):542-3.
-
2000: Lane D; Carroll D; Ring C; Beevers D G; Lip G Y
Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction.
Journal of psychosomatic research 2000;49(4):229-38.
-
2000: Lip G Y
Hypertension and the prothrombotic state.
Journal of human hypertension 2000;14(10-11):687-90.
-
2000: Lip G Y; Lydakis C; Nuttall S L; Landray M J; Watson R D; Blann A D
A pilot study of streptokinase-induced endothelial injury and platelet activation following acute myocardial infarction.
Journal of internal medicine 2000;248(4):316-8.
-
2000: Lip G Y; Felmeden D C; Li-Saw-Hee F L; Beevers D G
Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?
European heart journal 2000;21(20):1653-65.
-
2000: Li-Saw-Hee F L; Blann A D; Lip G Y
Effect of degree of blood pressure on the hypercoagulable state in chronic atrial fibrillation.
The American journal of cardiology 2000;86(7):795-7, A9.
-
2000: Steiner M K; Clarkson P B; Lip G Y
Myocardial infarction complicating hormone replacement therapy in a young woman with normal coronary arteries.
International journal of clinical practice 2000;54(7):475-7.
-
2000: Blann A D; Amiral J; McCollum C N; Lip G Y
Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls.
Atherosclerosis 2000;152(1):29-34.
-
2000: Li-Saw-Hee F L; Edmunds E; Blann A D; Beevers D G; Lip G Y
Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy.
International journal of cardiology 2000;75(1):43-7.
-
2000: Lip G Y; Beevers M; Beevers D G
Do patients with de novo hypertension differ from patients with previously known hypertension when malignant phase hypertension occurs?
American journal of hypertension 2000;13(8):934-9.
-
2000: Goldsmith I R; Foo L S; Blann A D; Lip G Y
Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty.
Clinical cardiology 2000;23(8):587-90.
-
2000: Felmeden D; Singh S P; Lip G Y
Anomalous coronary arteries of aortic origin.
International journal of clinical practice 2000;54(6):390-4.
-
2000: Goldsmith I R; Blann A D; Patel R L; Lip G Y
Reduced indexes of left atrial hypercoagulability in patients with severe mitral regurgitation.
The American journal of cardiology 2000;86(2):234-6.
-
2000: Lip P L; Belgore F; Blann A D; Hope-Ross M W; Gibson J M; Lip G Y
Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Investigative ophthalmology & visual science 2000;41(8):2115-9.
-
2000: Kamath S; Lip G Y
Managing cardiac arrhythmias. Part II. Management strategies for specific cardiac arrhythmias.
The Practitioner 2000;244(1611):568-73.
-
2000: Kamath S; Lip G Y
Managing cardiac arrhythmias. Part I. General principles of investigation and management.
The Practitioner 2000;244(1611):559, 560, 563-5.
-
2000: Li-Saw-Hee F L; Blann A D; Lip G Y
A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.
Journal of the American College of Cardiology 2000;35(7):1926-31.
-
2000: Spencer C G; Lip G Y
Haemorheological factors in hypertension.
Journal of human hypertension 2000;14(5):291-3.
-
2000: Beevers D G; Lip G Y
Do alpha blockers cause heart failure and stroke? Observations from ALLHAT.
Journal of human hypertension 2000;14(5):287-9.
-
2000: Goldsmith I R; Blann A D; Patel R L; Lip G Y
von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair.
The American journal of cardiology 2000;85(10):1218-22.
-
2000: Gibbs C R; Lip G Y
Takayasu's pulseless disease.
Clinical cardiology 2000;23(4):293-4.
-
2000: Li-Saw-Hee F L; Blann A D; Lip G Y
Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Stroke; a journal of cerebral circulation 2000;31(4):828-33.
-
2000: Edmunds E; Beevers D G; Lip G Y
What has happened to malignant hypertension? A disease no longer vanishing.
Journal of human hypertension 2000;14(3):159-61.
-
2000: Gibbs C R; Lip G Y; Beevers D G
Salt and cardiovascular disease: clinical and epidemiological evidence.
Journal of cardiovascular risk 2000;7(1):9-13.
-
2000: Gibbs C R; Jackson G; Lip G Y
ABC of heart failure. Non-drug management.
BMJ (Clinical research ed.) 2000;320(7231):366-9.
-
2000: Edmunds E; Lip G Y
An independent verdict: does infection with Helicobacter pylori cause ischaemic heart disease?
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2000;32(1):69-70.
-
2000: Lip G Y; Beevers M; Beevers D G
Serum urate is associated with baseline renal dysfunction but not survival or deterioration in renal function in malignant phase hypertension.
Journal of hypertension 2000;18(1):97-101.
-
2000: Watson R D; Gibbs C R; Lip G Y
ABC of heart failure. Clinical features and complications.
BMJ (Clinical research ed.) 2000;320(7229):236-9.
-
2000: Davis R C; Hobbs F D; Lip G Y
ABC of heart failure. History and epidemiology.
BMJ (Clinical research ed.) 2000;320(7226):39-42.
-
2000: Felmeden D C; Lip G Y; Beevers M; Beevers D G
The placebo effect and white coat effect in isolated systolic hypertension and systo-diastolic hypertension.
Blood pressure 2000;9(6):335-9.
-
2000: Felmeden D C; Lip G Y
Hormone replacement therapy and hypertension.
Blood pressure 2000;9(5):246-9.
-
2000: Belgore F M; Lip G Y; Blann A D
Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers.
British journal of biomedical science 2000;57(3):207-13.
-
1999: Spencer C G; Lip G Y; Beevers D G
Recurrent malignant hypertension: a report of two cases and review of the literature.
Journal of internal medicine 1999;246(5):513-6.
-
1999: Lip G Y
Atrial fibrillation in general practice.
The Practitioner 1999;243(1603):746-51.
-
1999: Blann A D; Li-Saw-Hee F; Lip G Y; Minamino T; Kitakaze M; Sanada S; Asanuma H; Kurotobi T; Koretsune Y; Fukunami M; Kuzuya T; Hoki N; Hori M
Increased membrane and soluble P-selectin in atrial fibrillation.
Circulation 1999;100(17):e86-7.
-
1999: Lane D; Carroll D; Lip G Y
Psychology in coronary care.
QJM : monthly journal of the Association of Physicians 1999;92(8):425-31.
-
1999: Lip G Y; Blann A D; Beevers D G
Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension.
Journal of hypertension 1999;17(8):1203-7.
-
1999: Lip G Y
Antihypertensive agents and left ventricular hypertrophy with 'usual' care in the population setting.
Journal of human hypertension 1999;13(8):497-8.
-
1999: Blann A; Kumar P; Krupinski J; McCollum C; Beevers D G; Lip G Y
Soluble intercelluar adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10(5):277-84.
-
1999: Lip G Y; Douglas M; Gupta A; Beevers D G
Urinary sodium excretion and blood pressure in chronic psychiatric in-patients.
Journal of human hypertension 1999;13(7):461-6.
-
1999: Lip G Y; Ferner R E
Diuretic therapy for hypertension: a cancer risk?
Journal of human hypertension 1999;13(7):421-3.
-
1999: Lydakis C; Lip G Y; Beevers M; Beevers D G
Atenolol and fetal growth in pregnancies complicated by hypertension.
American journal of hypertension 1999;12(6):541-7.
-
1999: Gibbs C R; Beevers D G; Lip G Y
The management of hypertensive disease in black patients.
QJM : monthly journal of the Association of Physicians 1999;92(4):187-92.
-
1999: Li-Saw-Hee F L; Blann A D; Goldsmith I; Lip G Y
Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.
The American journal of cardiology 1999;83(8):1206-9.
-
1999: Lip G Y; Gibbs C R
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
Journal of the American College of Cardiology 1999;33(5):1424-6.
-
1999: Li-Saw-Hee F L; Lip G Y
Atrial fibrillation, thromboembolism and antithrombotic therapy.
International journal of clinical practice 1999;53(2):110-7.
-
1999: Lip G Y
Thromboprophylaxis for atrial fibrillation.
Lancet 1999;353(9146):4-6.
-
1999: Landray M J; Lip G Y
White coat hypertension: a recognised syndrome with uncertain implications.
Journal of human hypertension 1999;13(1):5-8.
-
1999: Landray M J; Sagar G; Murray S; Beevers M; Beevers D G; Lip G Y
White coat hypertension and carotid atherosclerosis.
Blood pressure 1999;8(3):134-40.
-
1998: Lydakis C; Beevers D G; Beevers M; Lip G Y
Obstetric and neonatal outcome following chronic hypertension in pregnancy among different ethnic groups.
QJM : monthly journal of the Association of Physicians 1998;91(12):837-44.
-
1998: Lip G Y
Beta-blockers in hypertension: to reappraise or to call a halt?
Journal of human hypertension 1998;12(12):799-801.
-
1998: Lip G Y; Beevers M; Beevers D G
The 'Birmingham Hypertension Square' for the optimum choice of add-in drugs in the management of resistant hypertension.
Journal of human hypertension 1998;12(11):761-3.
-
1998: Lip P L; Jones A F; Price N; Headon M; Beevers D G; Lip G Y
Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy?
Acta ophthalmologica Scandinavica 1998;76(5):533-6.
-
1998: Lydakis C; Chaudary A Y; Lip G Y
The 'vasovagal effect' of nitrates: an under-recognised complication of nitrate use.
International journal of clinical practice 1998;52(6):418-21.
-
1998: Beevers D G; Lip G Y
JNC-VI: a view from the United Kingdom.
Journal of human hypertension 1998;12(9):649-51.
-
1998: Lip G Y; Singh S P; Beevers D G
Aortic coarctation diagnosed after hypertension in pregnancy.
American journal of obstetrics and gynecology 1998;179(3 Pt 1):814-5.
-
1998: Landray M J; Nuttall S L; Lydakis C; Martin U; Maxwell S R; Lip G Y
Oxidative stress after thrombolysis.
Lancet 1998;352(9132):960.
-
1998: Lip G Y; Ray K K; Shiu M F
Coronary spasm in acute myocardial infarction.
Heart (British Cardiac Society) 1998;80(2):197-9.
-
1998: Blann A D; Lip G Y
Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1998;15(8):634-42.
-
1998: Lip G Y; Bawden L; Hodson R; Rutland E; Snatchfold J; Beevers D G
Atrial fibrillation amongst the Indo-Asian general practice population. The West Birmingham Atrial Fibrillation Project.
International journal of cardiology 1998;65(2):187-92.
-
1998: Lip G Y; Lydakis C; Zarifis J; Messerli F H
Regression of LVH or improved prognosis (or both): what is the question?
Journal of human hypertension 1998;12(7):423-5.
-
1998: Lydakis C; Lip G Y
Microalbuminuria and cardiovascular risk.
QJM : monthly journal of the Association of Physicians 1998;91(6):381-91.
-
1998: Blann A D; Lip G Y
The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(4):297-306.
-
1998: Landray M J; Sagar G; Muskin J; Murray S; Holder R L; Lip G Y
Association of atherogenic low-density lipoprotein subfractions with carotid atherosclerosis.
QJM : monthly journal of the Association of Physicians 1998;91(5):345-51.
-
1998: Li-Saw-Hee F L; Lip G Y
Digoxin revisited.
QJM : monthly journal of the Association of Physicians 1998;91(4):259-64.
-
1998: Gibbs C R; Lip G Y
Do we still need dipyridamole?
British journal of clinical pharmacology 1998;45(4):323-8.
-
1998: Gibbs C R; Li-Saw-Hee F L; Lip G Y
Up to date review of the secondary preventive measures for recurrent ischaemic stroke and transient ischaemic episodes.
Scottish medical journal 1998;43(1):6.
-
1998: Lydakis C; Kerr H; Hutchings K; Lip G Y
Women's awareness of, and attitudes towards, hormone replacement therapy: ethnic differences and effects of age and education.
International journal of clinical practice 1998;52(1):7-12.
-
1998: Lip P L; Blann A D; Jones A F; Lip G Y
Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
Eye (London, England) 1998;12 ( Pt 2)():245-51.
-
1997: Lip G Y; Beevers D G
'Reverse dipping' on ambulatory blood pressure monitoring.
Journal of human hypertension 1997;11(12):821-2.
-
1997: Blann A D; Lip G Y
Platelets and hypertension: the pressure is on the clot.
Journal of human hypertension 1997;11(12):763-4.
-
1997: Lip G Y; Blann A D; Jones A F; Lip P L; Beevers D G
Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
The American journal of cardiology 1997;80(12):1566-71.
-
1997: Lydakis C; Hollinrake K; Lip G Y
An unusual cause of palpitations requiring atrioventricular node ablation and pacemaker therapy.
Blood pressure 1997;6(6):368-71.
-
1997: Lydakis C; Efstratopoulos A; Lip G Y
Microalbuminuria in hypertension: is it up to measure?
Journal of human hypertension 1997;11(11):695-7.
-
1997: Lip G Y
Atrial fibrillation in hypertension: under recognised or over diagnosed?
Journal of human hypertension 1997;11(11):691-3.
-
1997: Lip G Y; Beevers M; Beevers D G
Does renal function improve after diagnosis of malignant phase hypertension?
Journal of hypertension 1997;15(11):1309-15.
-
1997: Lip G Y; Churchill D; Beevers M; Auckett A; Beevers D G
Angiotensin-converting-enzyme inhibitors in early pregnancy.
Lancet 1997;350(9089):1446-7.
-
1997: Felmeden D; Lip G Y; Beevers D G
Fibromuscular dysplasia.
Journal of human hypertension 1997;11(10):687-8.
-
1997: Lip G Y; Blann A D; Jones A F; Beevers D G
Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis.
American heart journal 1997;134(4):764-71.
-
1997: Lip G Y; Beevers M; Beevers D G
Malignant hypertension in young women is related to previous hypertension in pregnancy, not oral contraception.
QJM : monthly journal of the Association of Physicians 1997;90(9):571-5.
-
1997: Li-Saw-Hee F L; Blann A D; Lip G Y
The detection of endothelial dysfunction in patients with essential hypertension.
International journal of cardiology 1997;61(2):171-4.
-
1997: Lip G Y; Beevers D G
Can we treat coronary artery disease with antibiotics?
Lancet 1997;350(9075):378-9.
-
1997: Lip G Y
Can we treat hypertensive menopausal women with hormone replacement therapy?
Journal of human hypertension 1997;11(7):397-9.
-
1997: Lip G; Zarifis J; Beevers D G
Acute admissions with heart failure to a district general hospital serving a multiracial population.
International journal of clinical practice 1997;51(4):223-7.
-
1997: Beevers D G; Lip G Y
Angiotensin II receptor antagonists, elite drugs (or not) for patients with heart failure or hypertension?
Journal of human hypertension 1997;11(6):329-30.
-
1997: Blann A D; Lip G Y; Beevers D G; McCollum C N
Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
Thrombosis and haemostasis 1997;77(6):1077-80.
-
1997: Lip G Y; Blann A
von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?
Cardiovascular research 1997;34(2):255-65.
-
1997: Lip G Y
Hypercoagulability and haemodynamic abnormalities in atrial fibrillation.
Heart (British Cardiac Society) 1997;77(5):395-6.
-
1997: Lip G Y
Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk?
Lancet 1997;349(9065):1565-6.
-
1997: Lip G Y; Beevers M; Churchill D; Shaffer L M; Beevers D G
Effect of atenolol on birth weight.
The American journal of cardiology 1997;79(10):1436-8.
-
1997: Lip G Y
The left atrium in hypertension, an appendage often forgotten.
Journal of human hypertension 1997;11(3):145-7.
-
1997: Zarifis J; Beevers G; Lip G Y
Acute admissions with atrial fibrillation in a British multiracial hospital population.
The British journal of clinical practice 1997;51(2):91-6.
-
1997: Lip G Y; Zarifis J; Farooqi I S; Page A; Sagar G; Beevers D G
Ambulatory blood pressure monitoring in acute stroke. The West Birmingham Stroke Project.
Stroke; a journal of cerebral circulation 1997;28(1):31-5.
-
1996: Lip G Y; Adeotoye O A; Zarifis J; Singh S P; Watson R D; Beevers D G
Ambulatory blood pressure monitoring in patients with single chamber ventricular pacemakers (VVI pacing mode)
American journal of hypertension 1996;9(12 Pt 1):1240-1.
-
1996: Lip G Y
Commentary: do angiotensin II receptor antagonists regress left ventricular hypertrophy?
Journal of human hypertension 1996;10(11):725-7.
-
1996: Beevers D G; Lip G Y
Does non-malignant essential hypertension cause renal damage? A clinician's view.
Journal of human hypertension 1996;10(10):695-9.
-
1996: Lip G Y; Cader M Z; Lee F; Munir S M; Beevers D G
Ethnic differences in pre-admission levels of physical activity in patients admitted with myocardial infarction.
International journal of cardiology 1996;56(2):169-75.
-
1996: Lip G Y; Zarifis J; Beevers M; Beevers D G
Ambulatory blood pressure monitoring in atrial fibrillation.
The American journal of cardiology 1996;78(3):350-3.
-
1996: Lip G Y; Lip P L; Zarifis J; Watson R D; Bareford D; Lowe G D; Beevers D G
Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin.
Circulation 1996;94(3):425-31.
-
1996: Zarifis J; Lip G Y; Leatherdale B; Beevers G
Malignant hypertension in association with primary aldosteronism.
Blood pressure 1996;5(4):250-4.
-
1996: Lip G Y; Lowe G D
Warfarin and aspirin as thromboprophylaxis in atrial fibrillation.
British journal of clinical pharmacology 1996;41(5):369-79.
-
1996: Lip G Y; Beevers G; Zarifis J; Singh S P
Value of ECGs in identifying heart failure due to left ventricular systolic dysfunction. ECGs are valuable in hospital as well as general practice.
BMJ (Clinical research ed.) 1996;312(7039):1161.
-
1996: Lip G Y; Luscombe C; McCarry M; Malik I; Beevers G
Ethnic differences in public health awareness, health perceptions and physical exercise: implications for heart disease prevention.
Ethnicity & health 1996;1(1):47-53.
-
1996: Lip G Y; Zarifis J; Watson R D; Beevers D G
Physician variation in the management of patients with atrial fibrillation.
Heart (British Cardiac Society) 1996;75(2):200-5.
-
1996: Lip G Y; Beevers D G; Coope J R
ABC of atrial fibrillation. Atrial fibrillation in general and hospital practice.
BMJ (Clinical research ed.) 1996;312(7024):175-8.
-
1996: Lip G Y; Watson R D; Singh S P
ABC of atrial fibrillation. Cardioversion of atrial fibrillation.
BMJ (Clinical research ed.) 1996;312(7023):112-5.
-
1996: Lip G Y; Lowe G D
ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation.
BMJ (Clinical research ed.) 1996;312(7022):45-9.
-
1995: Lip G Y; Blann A D; Zarifis J; Beevers M; Lip P L; Beevers D G
Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Journal of hypertension 1995;13(12 Pt 2):1674-8.
-
1995: Lip G Y; Watson R D; Singh S P
ABC of atrial fibrillation. Drugs for atrial fibrillation.
BMJ (Clinical research ed.) 1995;311(7020):1631-4.
-
1995: Lip G Y; Singh S P; Watson R D
ABC of atrial fibrillation. Investigation and non-drug management of atrial fibrillation.
BMJ (Clinical research ed.) 1995;311(7019):1562-5.
-
1995: Lip G Y; Beevers D G; Singh S P; Watson R D
ABC of atrial fibrillation. Aetiology, pathophysiology, and clinical features.
BMJ (Clinical research ed.) 1995;311(7017):1425-8.
-
1995: Lip G Y; Beevers G; Zarifis J
Hormone replacement therapy and cardiovascular risk: the cardiovascular physicians' viewpoint.
Journal of internal medicine 1995;238(5):389-99.
-
1995: Lip G Y; Beevers D G
ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation.
BMJ (Clinical research ed.) 1995;311(7016):1361-3.
-
1995: Lip G Y
Does atrial fibrillation confer a hypercoagulable state?
Lancet 1995;346(8986):1313-4.
-
1995: Lip G Y; Beevers M; Potter J F; Beevers D G
Malignant hypertension in the elderly.
QJM : monthly journal of the Association of Physicians 1995;88(9):641-7.
-
1995: Lip G Y; Beevers M; Beevers D G
Complications and survival of 315 patients with malignant-phase hypertension.
Journal of hypertension 1995;13(8):915-24.
-
1995: Lip G Y; Jones A F
Lipoprotein (a) and vascular disease: thrombogenesis and atherogenesis.
QJM : monthly journal of the Association of Physicians 1995;88(8):529-39.
-
1995: Lip G Y; Malik I; Luscombe C; McCarry M; Beevers G
Dietary fat purchasing habits in whites, blacks and Asian peoples in England--implications for heart disease prevention.
International journal of cardiology 1995;48(3):287-93.
-
1995: Lip G; Beevers M; Churchill D; Beevers D G
Do clinicians prescribe HRT for hypertensive postmenopausal women?
The British journal of clinical practice 1995;49(2):61-4.
-
1995: Lip G Y; Beevers M; Zarifis J; Beevers G
Seasonal variations in fatal pulmonary embolism. Malignant phase hypertension does not vary by season.
BMJ (Clinical research ed.) 1995;310(6972):129-30.
-
1995: Lip G Y; Zarifis J; Beevers M; Beevers D G
Duration of cough following cessation of ACE inhibitor therapy.
American journal of hypertension 1995;8(1):98.
-
1994: Lip G Y; Beevers M; Beevers G
The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England.
Journal of hypertension 1994;12(11):1297-305.
-
1994: Farooqi I S; Dar S; Farooqi S; Beevers D G; Lip G Y
A comparative study of risk factors for acute myocardial infarction amongst men of Indo-origin in Trinidad and the UK.
International journal of cardiology 1994;47(1):45-9.
-
1994: Lip G Y; Metcalfe M J
Have we identified the factors affecting prognosis following coronary artery bypass surgery?
The British journal of clinical practice 1994;48(6):317-22.
-
1994: Lip G Y; Beevers D G
Abnormalities of rheology and coagulation in hypertension.
Journal of human hypertension 1994;8(9):693-702.
-
1994: Lip G Y; Beevers M; Churchill D; Beevers D G
Hormone replacement therapy and blood pressure in hypertensive women.
Journal of human hypertension 1994;8(7):491-4.
Sign-in to see more